University of Louisville

ThinkIR: The University of Louisville's Institutional Repository
Electronic Theses and Dissertations
12-2016

Using a mouse model to investigate male bias in autism spectrum
disorder incidence.
Elizabeth Ann Gordon
University of Louisville

Follow this and additional works at: https://ir.library.louisville.edu/etd
Part of the Endocrinology Commons

Recommended Citation
Gordon, Elizabeth Ann, "Using a mouse model to investigate male bias in autism spectrum disorder
incidence." (2016). Electronic Theses and Dissertations. Paper 2608.
https://doi.org/10.18297/etd/2608

This Doctoral Dissertation is brought to you for free and open access by ThinkIR: The University of Louisville's
Institutional Repository. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized
administrator of ThinkIR: The University of Louisville's Institutional Repository. This title appears here courtesy of the
author, who has retained all other copyrights. For more information, please contact thinkir@louisville.edu.

USING A MOUSE MODEL TO INVESTIGATE MALE BIAS IN AUTISM
SPECTRUM DISORDER INCIDENCE

By
Elizabeth Ann Gordon
B.S., Murray State University, 2008
M.P.H., University of Louisville, 2010

A Dissertation
Submitted to the Faculty of the
College of Arts and Sciences of the University of Louisville
in Partial Fulfillment of the Requirements
for the Degree of

Doctor of Philosophy in Biology

Department of Biology
University of Louisville
Louisville, Kentucky

December 2016

Copyright 2016 by Elizabeth Ann Gordon

All rights reserved

USING A MOUSE MODEL TO INVESTIGATE MALE BIAS IN AUTISM
SPECTRUM DISORDER INCIDENCE

By
Elizabeth Ann Gordon
B.S., Murray State University 2008
M.P.H., University of Louisville 2010

A Dissertation Approved on
November 11, 2016
by the following Dissertation Committee:

_________________________________________
Dissertation Director
Dr. Cynthia Corbitt
_________________________________________
Dr. Keith Lyle
_________________________________________
Dr. Holly Swain Ewald
_________________________________________
Dr. Mark Running
_________________________________________
Dr. Manuel Casanova

ii

ABSTRACT
USING A MOUSE MODEL TO INVESTIGATE MALE BIAS IN AUTISM
SPECTRUM DISORDER INCIDENCE
Elizabeth Ann Gordon
November 11, 2016
The review (Chapter 1) overviews our current understanding of the sex bias in
autism spectrum disorders (ASD), whereby males are 4 times more likely to develop the
condition. The longstanding uncertainty surrounding the etiology of autism can be
informed by inclusion of both sexes in future research to better understand the
mechanism responsible for this sex bias. Both clinical studies and animal models are
useful tools to elucidate the underlying cause(s) of sexual dimorphic morphological,
physiological, and behavioral differences in the ASD phenotype.
Sex differences in social behaviors are common across species, underscoring the
importance of assessing baseline sex differences in behavior, especially when sexually
dimorphic effects on behavior are expected. I examined pre-pubertal behavior (Chapter 2)
in 3 strains of mice (C57BL/6, CFW, and CF1) using a wheel-running assay developed to
be relevant to autism-like behaviors. The results indicated no sex differences in wheel
running behaviors or social interaction with all mouse strains displaying typical wheel
running behavior, i.e. more time running on the wheel when it would turn and increased
performance of other activities when it was jammed.
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Studies have found that elevated levels of fetal testosterone (fT) are correlated
with later ASD diagnosis. Prenatal valproic acid (VPA) treatment is a common animal
model of ASD in rodents, mimicking many of the features of ASD including increased
male vulnerability. I used the VPA model (Chapter 3) to evaluate sex-specific responses
to prenatal VPA treatment, and to assess if masculinization of females with perinatal
testosterone propionate (TP) after prenatal VPA treatment would masculinize their
susceptibility for abnormalities in development relevant to ASD. My findings confirmed
that VPA exposure results in impaired motor development abilities, and provide novel
evidence that the combined effects of VPA, TP, and maleness (triple hit) led to more
severe motor development deficiencies in some tasks. I also present evidence that the
triple hit resulted in reduced anxiety, but elevated cognitive rigidity and self-grooming
compared to control females. The results provide some evidence for increased
vulnerability of triple hit males to behavioral deficits relevant to ASD, but more research
is needed to better understand this effect.
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CHAPTER 1
SEX DIFFERENCES IN ASD: EVIDENCE FROM CLINICAL STUDIES AND
ANIMAL MODELS

1. Introduction
Autism spectrum disorders (ASD, also referred to as autism) are behaviorally
defined by the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSMV) as characterized by deficits in social communication and social interaction, including
social-emotional reciprocity, nonverbal communication, and development and
maintenance of relationships (Diagnostic and Statistical Manual of Mental Disorders,
2013). Diagnosis also requires restricted, repetitive patterns of behavior, interests, or
activities, which may include hyper- or hypo-reactivity to sensory input (Diagnostic and
Statistical Manual of Mental Disorders, 2013). The autism phenotype is highly
heterogeneous with a wide range of symptoms, severities, and co-morbidities, including
intellectual impairment, anxiety, and epilepsy (Amaral, Schumann, & Nordahl, 2008).
Although agreement has yet to be reached regarding the level of genetic contribution to
autism (estimates range from 40 % to 90 % (Rybakowski et al., 2016)), the current
consensus is that in most cases the interaction of genes and the environment result in the
ASD phenotype (Tordjman et al., 2014). Due to the nature of the early onset of autism
within the first 3 years of life, most environmental etiologies are implicated prenatally or
during early development (Casanova, 2007; Tordjman et al., 2014). Autism is heavily
1

biased towards males (Auyeung, Taylor, Hackett, & Baron-Cohen, 2010), with ratios
ranging from 4:1 for classic autism to 11:1 in individuals with Asperger Syndrome
(Baron-Cohen et al., 2011). This sex bias could hold important information about the
mechanisms underlying ASD, but the cause(s) of this bias remains unknown. Just as ASD
is a multifactorial condition resulting from the interaction of multiple factors, it is likely
that the sex bias presented in ASD is also complex and is multiply determined.
2. Sex differences in ASD
2.1 ASD prevalence by sex
The prevalence of autism has climbed over past decades, with the latest estimates
from 2012 data at 1 in 68 eight year olds affected, which is the same as in 2010, but
roughly 30% higher than that of 2008 (1 in 88) and 120% higher than 2002 (1 in 150),
according to the CDC's Autism and Developmental Disabilities Monitoring (ADDM)
Network (Center for Disease Control and Prevention, 2016). Males continue to
significantly outnumber females in diagnoses. Sex bias was noted in the initial
descriptions of autism with eight of eleven cases described by Kanner (1943) and all four
cases reviewed by Asperger (1944) being male. This sex difference is a distinction that
holds true today, although recent work has begun to question the implications and true
extent of this difference.
Assessments of the sex ratio in ASD vary widely, from conservative estimates of
the M:F ratio around 2:1 (Eric Fombonne, 2005; Idring, 2014) to estimates as high as
16:1 (E. Fombonne, 2009; Kreiser & White, 2014). The heterogeneous nature of ASD
leads to variability of the sex ratio with males over-represented among high functioning
cases, but the sexes being more equally represented among those with severe intellectual
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disability (ID) (M. C. Lai, Lombardo, Auyeung, Chakrabarti, & Baron-Cohen, 2015;
Werling & Geschwind, 2013). However, the most commonly cited sex ratio for classic
autism is 4:1 (E. Fombonne, 2003; Eric Fombonne, 2005; Kreiser & White, 2014;
Werling & Geschwind, 2013), with higher estimates around 11:1 to 16:1 in individuals
with high functioning ASD, such as Asperger Syndrome (Baron-Cohen et al., 2011;
Kreiser & White, 2014; M. C. Lai, Lombardo, et al., 2015).
2.2 Diagnostic practices that may affect the sex ratio
Ascertainment procedures likely contribute to the variability in the sex ratio
(Alycia K. Halladay, 2015; Hiller, Young, & Weber, 2014; M. C. Lai, Lombardo, et al.,
2015); 2012 data from the CDC’s ADDM Network reported prevalence rates by sex were
highly variable across sites using different ascertainment procedures (Center for Disease
Control and Prevention, 2016). Typically, school or clinic based samples have a higher
M:F ratio than population screening (Werling & Geschwind, 2013). Studies identifying
cases by screening medical records and government registries have found M:F ratios of
4:1, 3.8:1, and 6:1 (Kohane et al., 2012; D. C. Lai, Tseng, Hou, & Guo, 2012; YearginAllsopp et al., 2003). Alternately, an epidemiological study of 5,484 children in Finland
found a much lower sex ratio, ~2:1 (Mattila et al., 2011). Furthermore, a study from
South Korea that surveyed from regular schools (general population), as well as special
education schools and a disability registry (high risk population) found the M:F ratios
were 2.5:1 and 5.1:1 in the general population sample and high-probability group,
respectively (Y. S. Kim et al., 2011).
Kreiser and White (2014) summarized the potential for under-identification of
females with ASD due to current diagnostic criteria (Kreiser & White, 2014). Numerous
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studies have reported sex differences in expression and severity of ASD symptoms,
including sex differences in social, attentional, and thought problems (Holtmann, Bolte,
& Poustka, 2007); variation in sensory symptoms, socio-communication difficulties, and
self-reported autistic traits (M. C. Lai et al., 2011); differences in repetitive stereotyped
behavior (RSB) and social problems (Mandy et al., 2012); and severity in cognitive
impairment, stereotyped mannerism, preoccupation with parts of objects, and
routines/rituals (Nicholas et al., 2008) (see section 2.3 for more detail). Given these sex
differences, females are less likely than males to meet diagnostic criteria for autism even
when displaying equivalently high levels of ASD traits (Dworzynski, Ronald, Bolton, &
Happe, 2012; Russell, Steer, & Golding, 2011). Dworzynski et al. (2012) also found the
diagnosis rate for girls with high scores on the Development and Wellbeing Assessment
(DAWBA) was lower (38%) than equally high scoring boys (56%) on the same
assessment tool. Kreiser and White (2014) pointed out that this could indicate that the
diagnostic instruments are not as valid for females (Lindsay & Widiger, 1995).
Additionally, there could be under-recognition by clinicians or other referrals sources
because of less severe difficulties or failure to display stereotypical autism-like behavior
in females (Mandy et al., 2012).
Because of the sex ratio in ASD prevalence, naturally, many studies include more
male participants, but others choose to limit their studies entirely to males. A metaanalysis of autism functional magnetic resonance imaging (fMRI) studies found that
many failed to report the sex ratio of participants; in research that did, 60% of studies
used only males and the remaining had a sex ratio of 15:1 (Philip et al., 2012). In another
meta-analysis focused on brain volumetric measurements of 496 autistics, 89% of
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participants were male (Via, Radua, Cardoner, Happe, & Mataix-Cols, 2011). These
examples are representative of most studies on ASD. While it may be easier to identify
and recruit males for ASD research, this could result in generalizations about our
understanding of autism that may be more representative of the male phenotype.
The male bias in ASD prevalence is highly variable across studies and could be
exaggerated due to ascertainment bias, under-recognition of females based on diagnostic
criteria, and over-representation of males for inclusion in research. The most recent
population-based epidemiological studies estimate the M:F ratio is less than the typically
reported 4:1 ratio, and is actually around 2:1 to 3:1 (M. C. Lai, Baron-Cohen, &
Buxbaum, 2015). Irrespective of the magnitude of a reporting and diagnostic bias, the
evidence clearly points to the existence of a sex bias in autism prevalence. The
mechanisms underlying this sex difference may provide information about the etiology
and development of ASD.
2.3 Sex differences in neurobiology and behavior
Studies evaluating sex differences in neurobiology and brain morphology are
limited; however, recent work has highlighted an effect of sex on neural development in
ASD (Alycia K. Halladay, 2015; M. C. Lai, Baron-Cohen, et al., 2015; M. C. Lai,
Lombardo, et al., 2015; M. C. Lai et al., 2013). Aside from the well documented sex
difference in the prevalence of ASD, the only other consistent finding regarding sex is
that females with ASD generally have lower intelligence quotient (IQ) scores than males
with ASD (Lord & Schopler, 1985; Lord, Schopler, & Revicki, 1982; Mandy et al., 2012;
Nicholas et al., 2008; Volkmar, Szatmari, & Sparrow, 1993). Since ASD is diagnosed
based on behavioral characteristics, sex differences in behavioral manifestations from this
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condition have been explored, but with inconsistent findings. Regardless, the current
evidence on sex differences in brain and behavioral phenotypes are described below.
2.3.1 Neurobiology
Ben-Itzchak et al (2013) found that among 663 autistic males and females (age 18
months-15 years), head size, as measured by mean head circumference, was larger in
males than females, while microcephaly was more prevalent in females than males (BenItzchak, Ben-Shachar, & Zachor, 2013). They also noted more frequent minor
neurological and musculoskeletal deficits in females, but no difference in severity,
cognitive ability, or adaptive functioning were observed between the sexes (Ben-Itzchak
et al., 2013). Bloss and Courchesne (2007) evaluated gray and white matter volumes for
the entire cerebrum, cerebral lobes, and cerebellum, along with total brain volume in a
sample of children with ASD (n=36, 9 girls) and neurotypical controls (n=27, 14 girls)
(Bloss & Courchesne, 2007). Unlike the differences found in head circumference, the
ASD girls in Bloss and Courchesne’s study displayed similar size-related abnormalities
as ASD boys (Bloss & Courchesne, 2007). However, they did find further irregularities in
ASD girls, such as enlarged white and gray matter volumes in the temporal lobes and
reduced cerebellar gray matter volume (Bloss & Courchesne, 2007).
A study by Schumann et al. (2009) focused on amygdala volumes taken from
MRI scans found that among 89 children (mean age=3 years), those receiving an ASD
diagnosis (n=41, 32 boys) had a larger amygdala when compared to normal developing
controls (n=39, 28 boys) and that the severity of communication and social deficiencies
was related to amygdala size (Schumann, Barnes, Lord, & Courchesne, 2009).
Interestingly, the ASD girls’ amygdala volume differed more significantly when
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compared to controls, while the relationship between amygdala size and behavioral
impairment was more significant in boys (Schumann et al., 2009). Schumann and
colleagues (2010) also performed a longitudinal study evaluating neural growth in
children aged 1.5 to 5 years (n=85, 41 with ASD and 44 controls) using structural MRI
from several time points (Schumann et al., 2010). They found enlarged cerebral gray and
white matter in children with ASD by age 2.5 and that all regions measured, except for
occipital gray matter, displayed an abnormal growth trajectory in ASD participants over
the longitudinal study (Schumann et al., 2010). This study also noted that abnormal
growth was pronounced in more brain regions in ASD females compared to ASD males
(Schumann et al., 2010).
Recent work by Nordahl et al. (2015) found sex differences in corpus callosum
alterations of preschool-aged children with ASD (n=139, 112 males) compared with
normally developing controls (n=82, 53 males) using a longitudinal study design
gathering structural and diffusion-weighted images (Nordahl et al., 2015). Children with
ASD of both sexes had a reduction in regional volume projecting to the superior frontal
cortex; however, there were sexually dimorphic patterns of projection from the corpus
callosum subregions to other areas in the frontal cortex with males having reduced
callosal region corresponding to the orbitofrontal cortex and females having a reduced
callosal region corresponding to the anterior frontal cortex (Nordahl et al., 2015). In
addition, they found increased diffusion properties of callosal fibers (mean diffusivity,
axial diffusivity, and radial diffusivity) in females, but not males, with ASD relative to
controls (Nordahl et al., 2015).
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Lai et al. (2013) evaluated high-functioning adults of both sexes with and without
ASD (n=120, n=30/group) and compared neuroanatomical features using voxel-based
morphometry (VBM) (M. C. Lai et al., 2013). They found nominal spatial overlap in grey
and white matter (2.3% and 1.0%, respectively) between males and females with ASD
(M. C. Lai et al., 2013). They suggest this indicates neuroanatomy developed differently
in autistic males and females and is altered from the neuroanatomy of same-sex controls
(M. C. Lai et al., 2013). The study also reported that atypical grey and white matter areas
in females with ASD overlapped with sexually dimorphic areas in controls providing
evidence of masculinization of these females (M. C. Lai et al., 2013). A study by Beacher
et al. (2012) also found sex-related anatomic features in adults with ASD. They assessed
volume measures using structural MRI, regional effects with VBM, and white matter
tract integrity using diffusion tensor imaging (Beacher et al., 2012). This group reported
associations between diagnosis and sex on measures of total white matter volume,
regional gray matter volume in the right parietal operculum, and white matter water
diffusion anisotropy in the body of the corpus callosum, cingulum, and corona radiata
(Beacher et al., 2012). Specifically, sex-related differences in healthy controls (n=30)
including larger fractional anisotropy and total white matter volume in males were
reduced or absent in ASD participants (n=28) (Beacher et al., 2012).
Overall, the current literature strongly supports sex differences in neural
development of children across many regions of the brain, including the temporal lobes
(Bloss & Courchesne, 2007), cerebellum (Bloss & Courchesne, 2007), amygdala
(Schumann et al., 2009), and corpus callosum (Nordahl et al., 2015). In addition, there is
evidence from studies in adults that the neuroanatomy of grey and white matter is altered
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in males and females with ASD (Beacher et al., 2012; M. C. Lai et al., 2013), and that
ASD females’ brains show masculinization (M. C. Lai et al., 2013). Taken together, this
evidence underscores the importance of evaluating sex differences in neurobiology and
that there could be both common and unique etiologies between the sexes in the
development of ASD.
2.3.2 Behavior
A study by Lord et al. (1982) of almost 500 children (age 3-8, ~80% male) with
mild to severe autism suggested that males performed better on eye-hand integration and
perception skills using the Psychoeducational Profile (PEP) and had higher nonverbal IQ
social quotient and Peabody Picture Vocabulary Test (PPVT) scores than females.
Controlling for nonverbal IQ resulted in loss of significance on the PPVT and on eyehand integration and perception scales, but the main effect of sex remained. Males also
displayed increased unusual visual responses and more stereotypic play compared to
females (Lord et al., 1982).
Using several standard measures of developmental and autistic behavior, Hartley
and Sikora (2009) found patterns of development, autism symptoms, and behavior
problems were similar in both sexes of young children aged 1.5-3.9 (n=199, 157 boys)
with ASD. However, girls with ASD showed more marked communication deficits,
additional sleep issues, and increased anxious and depressed affect compared to boys,
while boys displayed greater restricted, repetitive behavior (RRB) compared to girls
(Hartley & Sikora, 2009). Another study of toddlers (n=90, 68 boys, mean age 28
months) also found that girls showed weaker verbal skills, yet displayed stronger visual
reception skills compared to boys (Carter et al., 2007). In addition, they reported that
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boys had superior motor skills and more advanced social competence ratings than girls;
however, they failed to find a sex difference in RRB (Carter et al., 2007).
A large study of children and adolescents with a diagnosis of high functioning
ASD (n=325, 52 females) by Mandy et al. (2012) reported males to have more RRB by
parent report and direct observation using autism diagnostic observation schedule scores.
Analysis of associated features found that there were no sex differences for visuo-spatial
impairment, gross motor impairment, auditory sensitivity, feeding difficulties or
sensitivity to sound. Females were reported to have better fine motor skills than males,
but there was no difference in this measure in the younger half of the sample. Parents
reported higher levels of emotional symptoms for girls than boys on the Strengths and
Difficulties Questionnaire (SDQ), but all other problems were the same. According to
teacher report on the same measure, males were had a higher total problem score with
greater difficulties with hyperactivity/inattention and prosocial behavior (Mandy et al.,
2012).
A study of 83 adults (45 male) aged 18-45 with high-functioning ASD or
Asperger’s syndrome found that during interpersonal interaction, females showed less
autistic behavior than males in socio-communication and RRB domains, but had more
lifetime sensory symptoms and self-reported autistic traits. However, there was no sex
difference in self-reported systemizing, empathy, anxiety, depression, or obsessivecompulsive symptoms (M. C. Lai et al., 2011). McLennan et al. (1993) conducted a study
with 21 autistic females between the ages of 6 and 36, using 21 male autistic subjects
matched for age, diagnosis, and IQ. Overall, they found a significant main effect of sex in
social interaction measures with males displaying more abnormal behavioral
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development than females. However, more problems were identified in females when
assessing current friendships. Unlike some other studies, no sex difference for RRB or
nonsocial aspects of communication were found. Looking at the data within a more
narrow age range, males were also discovered to have more severe communication and
social problems at age 3 and ages 4-5 (McLennan, Lord, & Schopler, 1993).
Other studies have failed to find sex differences in the key features of ASD.
Holtmann et al. (2007) conducted a study of 23 males and 23 females (mean age ~12
years) with high-functioning ASD and reported no differences between the sexes in any
of the autism core symptoms (social interaction, communication, RRB). According to
parent report, though, females displayed more symptoms than males in social, attention,
and thought problem domains, such as peer relation impairments, social immaturity,
social dependence, inattentive, impulsive, or hyperactive behavior; however, parents’
perceptions could be influenced by sex-biased expectations of behavior (Holtmann et al.,
2007). Another study comparing 18 males and 18 females with an ASD diagnosis also
found no significant differences in autism symptomatology using 2 autism diagnostic
rating scales (Pilowsky, Yirmiya, Shulman, & Dover, 1998). In a larger study comparing
156 males and 43 females with autism, Volkmar and colleagues (1993) reported no sex
differences in the severity of autism symptoms, aside from the fact that autistic females
were more likely to have a lower IQ (Volkmar et al., 1993).
Many researchers have explored sex differences in behavioral manifestations of
autism, but with inconsistent and sometimes conflicting results. The variable results
among studies could be the consequence of numerous factors including small sample
size, difficulty recruiting adequate numbers of females, failure to match for factors like
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age, IQ, and changes in diagnostic criteria over time. Aside from issues with study
design, the heterogeneous nature of ASD as a “spectrum” disorder can make reaching a
consensus difficult, especially when considering sex differences in behavior. However,
regardless of these variations, the body of literature continues to indicate a higher
prevalence in the disorder for males, with differences in reporting or diagnosis perhaps
accounting for the discrepancy in the ratio of 2:1 to 4:1. It is also clear that in general,
females with ASD have lower IQ scores than males with ASD, and that many studies
have found variability in behavioral manifestations of the disorder. As more studies work
to include females and control for bias, a clearer picture of the true sex difference should
emerge.
3. Proposed mechanisms for sex differences
3.1 Genetic
The inheritance patterns of ASD from family and twin studies, and their
implication that genetic variation confers over half the risk for developing ASD (De
Rubeis & Buxbaum, 2015), prompted extensive research into identifying the genes that
may be significant causative factors (Muhle, Trentacoste, & Rapin, 2004). Genetic
studies have identified over 200 autism susceptibility genes(Tordjman et al., 2014), with
estimates that there could be up to 1200 ASD risk genes (De Rubeis & Buxbaum, 2015)
associated with this condition, and confirmed that ASD is a complex, multifactorial
disorder resulting from simultaneous action of genetic variants on multiple genes
(polygenetic) and by environmental factors (Tordjman et al., 2014). Given the
involvement of genetic mechanisms, an obvious explanation for the sex bias would be a
sex chromosome-linked effect.
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Due to the nature of mammalian inheritance, such that males have only one X
chromosome, many geneticists have explored genes on the X chromosome. Genetic
studies in those with ASD have found cases of associated loci on the X chromosome
including 4 genes: Fragile X mental retardation (Fmr1), Mecp2, and neuroligin (Nlgn) 3
and 4 (Paul H. Patterson, 2006). Fragile X syndrome (FXS) is caused by mutations in
Fmr1 and includes some symptoms similar to those in autism (mental retardation,
attention deficit, anxiety, seizures, stereotypic behaviors, and communication deficits).
Estimates indicate that 10-40% of those with FXS also meet criteria for autism diagnosis;
however, only 2-8% of autism cases involve FXS (Tordjman et al., 2014; Wassink,
Piven, & Patil, 2001). Mutations in neuroligin 3 and 4 are associated with autism, as well
as mental retardation (Jamain et al., 2003; Laumonnier et al., 2004). NLGN 3 and 4
promote protein processing and stimulation of synapse formation, aiding in the
development of connectivity within the brain (Chih, Afridi, Clark, & Scheiffele, 2004;
Comoletti et al., 2004). Mutations in Mecp2, the gene responsible for Rett syndrome, are
also found in those with autism and the two conditions have similar symptoms (Glaze,
2004). MECP2 regulates gene expression (e.g., Bdnf) and may link synaptic activity and
transcription (Neul & Zoghbi, 2004). An X chromosome-linked effect is the most
obvious explanation for the sex bias; however, all cases of associated loci on the X
chromosome (Fmr1, Mecp2, Nlgn 3 and Nlgn 4) cause significant intellectual disability
that is not seen across the spectrum of autism cases, and the number of ASD cases linked
with these genes represents only a small fraction of total ASD cases, not large enough to
explain the sex bias (Paul H. Patterson, 2006; Werling & Geschwind, 2013).
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Additionally, ASD transmission through families does not generally follow an X-linked
pattern of inheritance (Todd, 1993; Werling & Geschwind, 2013).
Inherited mutations on the Y chromosome are also of interest given mammalian
inheritance, yet this explanation is also implausible because father-to-son transmission of
a severe autism phenotype is rarely documented (Beaudet, 2006), and it would not
explain ASD in girls. However, those severely affected by the disease presumably have a
reduction in reproductive fitness, and the possibility of transmission in those with milder
phenotypes is unknown (Beaudet, 2006). Longstanding mutations on the Y chromosome
with association to autism are also improbable based on evidence comparing Y
chromosome haplotypes in autism to controls (Jamain et al., 2002).
Another mechanism used to elucidate effect of sex chromosomes on ASD risk is
to study individuals with sex chromosome aneuploidies. These individuals often have
increased autism-like symptoms and are more likely to develop autism (Schaafsma &
Pfaff, 2014). In Klinefelter syndrome (47, XXY) males often have language-based
learning disabilities (Geschwind, Boone, Miller, & Swerdloff, 2000) and display social
withdraw and higher levels of autistic traits (Tartaglia, Cordeiro, Howell, Wilson, &
Janusz, 2010; van Rijn & Swaab, 2011). According to Bishop et al. (2011) 47, XXY and
47, XYY boys are diagnosed with autism at a higher rate than the general population as a
whole, 10% and 20%, respectively. Both XXY males and XYY males, along with XXX
females, are registered for special education needs (SEN) and speech and language
therapy at a much higher rate than the general population, but XXX females do not
display an increased rate of ASD (Bishop et al., 2011). Females with Turner syndrome
(45, XO) are more likely than XX girls to be diagnosed with autism (3%) (Creswell,
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1999; Werling & Geschwind, 2013) and have problems with social relationships and peer
interactions (McCauley, Ito, & Kay, 1986). Based on observations that XXX females
have no increased autism risk while XXY males have a slight increased risk (10%) and
XYY males have a significant increased risk (20%), along with increased risk in XY
males compared to XX females, Werling and Geschwind (2013) proposed that the Y
chromosome could be a risk factor for ASD. Considering that XO females also have an
increased risk of autism, albeit smaller (3%), Werling and Geschwind (2013) go on to
assert that a second X chromosome could be protective (Werling & Geschwind, 2013).
Furthermore, it was observed in females with Turner syndrome that those with a
maternally inherited X chromosome had reduced social cognition when compared with
XO females with a paternally inherited X chromosome (Donnelly et al., 2000; Skuse et
al., 1997). Given this, others have proposed that it is imprinted genes that are expressed
from the paternal, but not maternal, X chromosome that are protective against ASD
(Skuse, 2000). This is supported by increased rates of autism in Klinefelter syndrome
cases, given that 40-50% result from maternal nondisjunction, meaning that
approximately half of these cases lack the potentially protective paternal X. Since all
XYY cases lack paternal X expression, along with 2 Y chromosomes, the observed
higher rate in XYY cases supports the protective paternal X hypothesis (Werling &
Geschwind, 2013).
3.2 Prenatal steroid hormones
Although the presence of the Y chromosome itself might not explain ASD
patterns, the sex-determining region of the Y chromosome (Sry) gene sets hormonallybased differentiation in motion by leading to testis formation. Sexual differentiation of
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the brain begins during prenatal development following the production of steroid
hormones, such as testosterone (T), by the fetal testes (Lenz, Nugent, & McCarthy,
2012). The classic Organizational-Activational Hypothesis proposed by Phoenix et al.
(1959), states that gonadal hormones organize brain regions during a critical period in
development, which produces differences in brain development and behavior between the
sexes (Phoenix, 1959). More recently, sex differences in brain molecular, cellular, and
neural systems have been described (Spring, Lerch, & Henkelman, 2007), including roles
for de novo neurosteroidogenesis (Lenz et al., 2012). These sexual dimorphisms can
affect how each sex develops a disease, their signs and symptoms of that disease, and
their response to therapy (Becker et al., 2005). The effect of endogenous steroids on
sexual differentiation of the brain, early life diagnosis of ASD, and higher incidence of
ASD in males, has launched investigations aimed at understanding the potential role of
steroid hormones in differential susceptibility of the sexes to ASD (Alycia K. Halladay,
2015; M. C. Lai et al., 2013; Schaafsma & Pfaff, 2014; Werling & Geschwind, 2013).
Multiple studies have found evidence that steroid hormones are atypical in those
with ASD (Schaafsma & Pfaff, 2014). Pre-pubertal autistic children (both boys and girls)
displayed increased levels of serum dehydroepiandrosterone (DHEA), serum
testosterone, and androstenedione, while serum follicle-stimulating hormone (FSH) levels
were decreased, compared to age and sex-specific normal lab reference ranges (Geier &
Geier, 2006, 2007). In a study comparing individuals with Asperger’s syndrome or highfunctioning autism to age and IQ-matched controls, serum androstenedione levels were
elevated in the ASD group (Ruta, Ingudomnukul, Taylor, Chakrabarti, & Baron-Cohen,
2011). Salivary testosterone levels were also elevated in pre-pubertal children with
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autism and Asperger syndrome and pubertal patients with autism compared to controls
(Schmidtova, 2010). In addition, in a survey of women, those with ASD reported
androgen-related conditions, including hirsutism, irregular menstrual cycles,
dysmenorrhea, polycystic ovarian syndrome (PCOS), severe acne, tomboyism,
bisexuality/asexuality, and a family history of ovarian, uterine, or prostate cancer, tumors,
or growths significantly more often than controls (Ingudomnukul, Baron-Cohen,
Wheelwright, & Knickmeyer, 2007).
Some researchers propose that the male bias in ASD diagnosis manifests from an
extreme expression of the psychological and physiological properties of the typical male
brain. This hypothesis suggests males require slight psychological and physiological
changes from normal males, while differences in females from their non-ASD
counterparts must be more extreme, to display the ASD phenotype; this is known as the
Extreme Male Brain (EMB) Theory (Baron-Cohen et al., 2011). Baron-Cohen and
colleagues propose that the EMB phenotype could result from elevated levels of fetal
testosterone (fT), an androgen receptor abnormality, or sexually dimorphic gene
expression unrelated to fT (Baron-Cohen, Knickmeyer, & Belmonte, 2005), but their
recent evidence supports the elevated fT premise (Baron-Cohen et al., 2014).
Multiple conditions result in an altered hormonal environment during fetal
development, providing insight into the effect that prenatal hormones have on the
developing brain (Gore, Martien, Gagnidze, & Pfaff, 2014). In females with congenital
adrenal hyperplasia (CAH), prenatal adrenal androgen production is elevated, which has
been associated with masculinized behavior and cognitive skills, including male preferred
playmates (Hines & Kaufman, 1994) and masculine attributes on some visual-spatial

17

tasks (Hines et al., 2003) (but see (McGuire, Ryan, & Omenn, 1975)). There is further
evidence in females with CAH of increased autistic-like behavioral and cognitive
characteristics; for example, CAH females exhibited higher scores on the autismspectrum quotient (AQ) than their unaffected female siblings and had reduced vocabulary
scores (Knickmeyer et al., 2006). In children whose mothers had polycystic ovary
syndrome with elevated blood testosterone during pregnancy, total AQ scores were
higher compared to controls, with many areas only significantly affected in daughters
(Palomba et al., 2012).
Furthermore, numerous studies have analyzed fT levels from amniotic fluid
samples in both sexes and found a relationship between fT levels and ASD indicators,
including autistic traits in toddlers (Auyeung et al., 2010), quality of social relationships
and restricted interests in boys at age 4 (Knickmeyer, Baron-Cohen, Raggatt, & Taylor,
2005), and scores on two measures of empathy in children ages 6-8 (Chapman et al.,
2006). A recent study found that fetal steroidogenic activity (including T and hormones
along the Δ4 biosynthetic pathway to T) is elevated (above that of controls) in utero for
boys and girls later diagnosed on the autism spectrum (Baron-Cohen et al., 2014). Given
that amniocentesis is primarily performed in high risk pregnancies, a longitudinal study
using umbilical blood taken at birth in both low- and high-risk pregnancies was
performed with results indicating no link between autistic behaviors or autism diagnosis
and perinatal testosterone levels (Whitehouse et al., 2012). However, T levels generally
peak during mid-pregnancy and are relatively low around the time of birth in humans
(Bao & Swaab, 2011; Swaab, 2004), so the window of vulnerability for developing
autism may have been missed in this study.
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3.3 Environmental mechanisms
Many modern diseases that significantly affect public health are a result of the
interaction of multiple genes with the environment. For example, heart disease, diabetes,
cancer, spina bifida/anencephaly, pyloric stenosis, cleft palate, COPD, mood disorders,
autism and others are thought to be complex conditions (Saito, 2011; Stolk et al., 2008).
Results from the largest population-based twin autism study to-date suggests that
environmental factors common to twins, not genetic factors, are responsible for
explaining the majority (about 55%) of the liability to autism (Hallmayer et al., 2011).
Many environmental mechanisms have been implicated in the development of ASD, and
some present potential mechanisms for the sex bias.
Human studies, as well as rodent models, demonstrate that prenatal stress impacts
the hypothalamic-pituitary-adrenal (HPA) axis, which can increase glucocorticoid
secretion even in adulthood and cause structural changes in the hippocampus, frontal
cortex, amygdala, and nucleus accumbens (Weinstock, 2008). Stress during pregnancy is
also shown to produce poorer cognitive outcomes in infants as measured by the Bayley
Mental Developmental Index scores (Markham, Taylor, Taylor, Bell, & Koenig, 2010)
and is linked to increased susceptibility to cognitive and emotional disorders, such as
depression, anxiety, schizophrenia, and autism (Mueller & Bale, 2007, 2008). Many of
the diseases mentioned above that are associated with prenatal or maternal stress show a
sex bias in incidence (Mueller & Bale, 2008).
Although the precise mechanism of immune dysfunction in those with ASD
remains unclear, research points to a link between the immune system and the
pathogenesis of autism (Cohly & Panja, 2005). A review by Rossignol and Frye (2012) of
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physiological abnormalities in autism found that 95% of publications implicated an
association between ASD and immune dysregulation or inflammation (416 out of 437
publications) (Rossignol & Frye, 2012). Further evidence suggests that microglial and
astrocyte activation, along with cytokine up-regulation, are present in the brain and
cerebrospinal fluid of autistic patients (P. H. Patterson, 2009). Maternal immune
activation (MIA) has been explored as a leading environmental factor that could increase
the risk of ASD by activating microglia and stimulating secretion of pro-inflammatory
cytokines (P. H. Patterson, 2009). In a nation-wide study of children born in Denmark
between 1980 and 2005, admission to the hospital due to maternal viral infection in the
first trimester and maternal bacterial infection in the second trimester were found to be
associated with diagnosis of ASD in the offspring (Atladottir et al., 2010). In addition,
maternal rubella infection is also associated with neurological and behavioral problems
including autism (Chess, Fernandez, & Korn, 1978); data from a rubella epidemic found
the incidence of autism diagnosis increased over 200-fold above normal for offspring
exposed prenatally (Chess, 1977).
Associations of maternal infections, inflammation, and ASD diagnosis lead to
questions regarding possible mechanisms leading to the sex bias in ASD. Interestingly,
immune cells in the brain are implicated in the development of sexually dimorphic brain
regions. To date, there are no clinical studies in this area given that most of the research
into the impact of sex steroid hormones on brain development is carried out in animals
(primarily rodents) (Lenz et al., 2012; McCarthy, Arnold, Ball, Blaustein, & De Vries,
2012; Park, Baum, Paredes, & Tobet, 1996; Tobet, Basham, & Baum, 1993). However,
connections between immune activation and mechanisms leading to increased
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vulnerability to ASD in males can be informed by research using rodent models. For
example, the pre-optic area (POA) is known to be a highly sexually dimorphic region
with male rats displaying more densely populated dendritic spines (Amateau &
McCarthy, 2002). Lenz et al. (2013) recently demonstrated that male rats had double the
number of ameboid microglia in their POA, and these microglia also displayed a more
activated morphological appearance compared to females (Lenz, Nugent, Haliyur, &
McCarthy, 2013). In addition, estradiol treatment of females masculinized microglial
number and morphology, resulting in masculinization of dendritic spine density and
male-typical adult copulatory behavior (note: in rodents testosterone from the male gonad
is converted to estradiol, a masculinizing agent, in the brain) (Lenz et al., 2013). Thus,
testosterone (via estradiol in rodents) increases the number and active morphologic
profile of microglia in the male neonatal brain. Human studies in those with sex
chromosome aneuploidies or conditions that alter hormonal milieu (i.e., CAH) have
identified similar mechanisms by which sex steroid hormones affect brain development
with testosterone as the main masculinizing agent (Bao & Swaab, 2011; Swaab, 2004).
This evidence offers a link between fetal immune response pathways and
masculinization, providing mechanisms whereby maternal immune activation of fetal
microglia could have sex-specific effects on brain development, including susceptibility
to neurodevelopmental disorders like ASD (Schaafsma & Pfaff, 2014).
Another environmental factor that has been associated with ASD development is
advanced parental age (≥35 for mothers and ≥40 for fathers) (Durkin et al., 2008).
Furthermore, some studies indicate that the sex ratio of children with an ASD diagnosis
can be influenced by parental age (Schaafsma & Pfaff, 2014). In a historical birth cohort
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study, risk of ASD increased significantly with each 10-year increase in both maternal
and paternal age; associations with parental age was slightly stronger for girls, but the sex
difference failed to reach statistical significance (Croen, Najjar, Fireman, & Grether,
2007). Another historical population-based cohort found a significant association
between advancing paternal, but not maternal, age and risk of ASD, where children of
men ≥40 were 5.75 times more likely to have ASD than children of men <30.
Interestingly, the M:F ratio in children with ASD whose fathers were 40 years or older
(2.3:1) was lower than sex ratio of fathers younger than 40 (5.6:1); however, the sample
was too small to test for statistical significance (Reichenberg et al., 2006). Finally, in a
study of families with ASD cases, the M:F ratio decreased significantly with increasing
paternal age even after adjusting for maternal age (6.2:1 from fathers <30 to 1.2:1 from
fathers aged >45); however, no significant relationship was found between maternal age
and M:F ratio (Anello et al., 2009). This implies that younger parental age is associated
with the typical male predominated sex bias in ASD; however, as parental age increases,
especially of fathers, this results in a more even sex distribution, or more cases of ASD in
females.
Numerous studies have examined potential genetic, hormonal, and environmental
mechanisms for the development of sex differences in ASD. While some X chromosomelinked cases have been explored, their infrequency limits their influence on the overall
sex difference in prevalence. However, more can be learned from sex chromosome
aneuploidies on the impact of sex chromosomes on this bias, specifically, if the Y
chromosome is a risk factor for ASD (i.e., beyond the SRY-directed formation of the
testis) and if the paternal X chromosome offers protective effects. A significant body of
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evidence supports elevated levels of both pre- and post-natal testosterone as increasing
one’s risk for ASD, but the mechanism for this occurrence and its level of influence on
the overall sex bias has yet to be determined. Finally, multiple environmental causes of
ASD development are being considered due to their ability to influence sexes differently.
As with the nature of multifactorial conditions, it is likely that many, if not all, of these
mechanisms contribute to the development of ASD and have the possibility to impact
males more directly than females. As with most areas of ASD research, more studies are
needed to better understand this phenomenon.
4. Animal models - sex differences in phenotypes
Animal research in the field of neuroscience has predominately used male animals
due to the assumption that cyclic female sex hormones may confound results (Cahill,
2012). A survey by Beery and Zucker (2009) reported a male bias in research across
disciplines, with the ratio of male-only to female-only studies in neuroscience around 5:1
and no mention of subject sex in 22–42% of articles (Beery & Zucker, 2011). New
emphasis has recently been given for researchers to recognize the significance of
considering sex and sex differences in the design and interpretation of studies ("Putting
gender on the agenda," 2010), which provides much needed information about sex
differences in animal models of diseases, like autism, that can be instrumental in
advancing our understanding of the impact of sex on the human condition.
4.1 Genetic
The complexity of ASD etiology and known genetic component has led to the
development of mouse models with targeted mutations of candidate genes (Oddi, Crusio,
D'Amato, & Pietropaolo, 2013). Recent advances in transgenic and recombinant
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technologies and the availability of the entire genome sequence allow genetic mouse
models of autism to provide better opportunities to understand the genotype-phenotype
relationship in autism (Bolivar, Walters, & Phoenix, 2007). With targeted mutations in
the mouse genome, researchers can test hypotheses about autism susceptibility genes and
apply relevant assays to identify potential aspects of the autism behavioral, histological,
or molecular phenotype (Crawley, 2007). Autism researchers are still developing model
systems for evaluating hypotheses about the genetic causes of ASD (Roullet & Crawley,
2011), and the work using these models to investigate potential sex differences is limited.
Nevertheless, just as in the human condition, sex differences in phenotype have been
described in genetic mouse models of autism.
Mouse models in autism research using mutations in the Fmr1 gene are common
because of the high proportion of individuals with FXS that also meet the diagnostic
criteria for autism (25-40%) (Roullet & Crawley, 2011; Wassink et al., 2001) (see section
3.1 for further information on FXS and autism). Fmr1 knockout mice display behaviors
relevant to ASD, including hyperactivity, high anxiety-like behaviors, low prepulse
inhibition (PPI) of acoustic startle, and slight impairment in maze learning (Roullet &
Crawley, 2011). Due to the sex differences in prevalence and phenotype in ASD,
researchers have begun using animal models of FXS to investigate any sex differences in
behavioral and physiological phenotype.
A study by Baker et al. (2010) explored spatial learning and memory in Fmr1
knockout (KO) mice with C57 albino background (Baker et al., 2010). Fmr1 KO mice
displayed behavioral differences when compared to wildtype (Wt) littermates, including
enhanced PPI and increased anxiety-like behaviors; however, there was no effect of sex
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on these behaviors (Baker et al., 2010). In other tests, such as platform test, trace fear
conditioning task, and cued Morris water maze, both sexes of KO mice displayed normal
performance (Baker et al., 2010). Another study evaluating sex differences in Fmr1 KO
mice produced similar findings using C57Bl/6 as the background strain. Overall, Fmr1
KO mice of both sexes exhibited audiogenic seizures, increased locomotor activity in the
open field test, less freezing in contextual fear conditioning, impaired memory in passive
avoidance examination, and increased PPI with low stimulus intensity. However, similar
effects were seen in both sexes and there was no effect of sex on the Fmr1 KO behavior
(Ding, Sethna, & Wang, 2014).
Behavioral testing has produced similar results in males and females of the Fmr1
KO mouse model of FXS, yet other assays have yielded sex differences. In a study of
expression of calcium-binding proteins in the dorsal thalamus of Fmr1 KO mice and Wt
littermates, males had a reduction in calbindin-immunoreactive cells in some dorsal
thalamic nuclei compared to Wt, while female KO mice did not show significant
differences (Giraldez-Perez et al., 2013). No sex differences in calbindin
immunoreactivity were observed in other areas of the brain, including the olfactory bulb,
cerebral cortex, claustroamygdaloid region, striatum, or hypothalamus (Giraldez-Perez et
al., 2013). As the stress response is often elevated in FXS, researchers sought to evaluate
serum glucocorticoid levels in the mouse model of FXS (Fmr1 KO). As is expected in
rodents, female animals had higher serum corticosterone levels than males in unstressed
conditions, and after an acute restraint, corticosterone levels increased in both sexes of
KO and Wt mice (Markham et al., 2010). The increase was similar for females of both
genotypes, but KO males showed an inhibited rise compared to Wt; however, both sexes
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of Fmr1 KO mice displayed a delayed return to baseline corticosterone levels following
stress, which is similar to human FXS patients (Markham, Beckel-Mitchener, Estrada, &
Greenough, 2006).
Phosphatase and tensin homolog on chromosome ten (PTEN) is a known tumor
suppressor gene with mutations associated with macrocephaly and autism; mice with
Pten null mutations express macroencephaly, neuronal hypertrophy, problems with
spatial learning, increased anxiety-like behaviors and activity, elevated acoustic startle
and diminished social interests (Roullet & Crawley, 2011). A study by Tilot et al. (2014)
induced a Pten mutation in mice and found that only male Ptenm3m4/m3m4 mice exhibited
decreased body size/weight compared to Wt littermates (Tilot et al., 2014). In a previous
study the same research group demonstrated that brain weight of Ptenm3m4/m3m4 mice is
double the brain weight of Wt animals, but there were not sex differences in brain growth
of the mice with the Pten mutation (Mester, Tilot, Rybicki, Frazier, & Eng, 2011; Tilot et
al., 2014). Male Pten mutant animals displayed increased social preference compared to
Wt, while female mutant mice behaved the same as Wt (Tilot et al., 2014). There were no
sex differences identified for other behavioral measures, such as novel object recognition,
tail flick, open field, or rotarod measures (Tilot et al., 2014).
Another group evaluated brain size and social behavior in mice with
haploinsufficiency for genes associated with increased susceptibility to ASD, PTEN
and/or Serotonin transporter (SLC6A4) (Page, Kuti, Prestia, & Sur, 2009). Pten functions
to regulate the PI3-kinase (PI3K) pathway, and SLC6A4 codes for a membrane-bound
protien that transports serotonin from the synaptic cleft to the presynaptic neuron; there is
biochemical evidence that these pathways interact (Page et al., 2009). In animals with
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haploinsufficiency for Pten or Slc6a4, both sexes displayed a macrocephaly phenotype,
while the compound heterozyous (Pten+/−; Slc6a4+/−) mice expressed exacerbated brain
overgrowth more severe than either single haploinsufficiency (Page et al., 2009). Pten
and Slc6a4 haploinsufficient female mice displayed social deficits compared with Wt
with the compound heterozyous mice displaying the most impairment; however, no
differences in social interaction were observed for any genotypes in the male groups
(Pten haploinsufficient, Slc6a4 haploinsufficient, and Pten+/−; Slc6a4+/−) (Page et al.,
2009). Both sexes of Pten haploinsufficient and Pten+/−; Slc6a4+/− mice had deficiencies
in prepulse inhibition of the acoustic startle response as compared to Wt but not as
compared to one another (Page et al., 2009).
Genetic mouse models of autism (or related conditions) are useful tools to better
elucidate the genotype-phenotype relationship. To date, limited sex differences in
behavior have been found in Fmr1 KO mice; however, sexual dimorphisms in
morphological and physiological traits have been identified in this model. Interestingly,
the Pten mutation resulted in increased brain weight in both sexes, but smaller body
weight in only males. In addition Pten mutated males displayed increased preference for
social target (opposite of that seen in ASD), while only the females with Pten mutations
displayed social deficits. More research is needed to further evaluate sex differences in
these and other genetic models of autism.
4.2 Valproic acid
Valproic acid (aka 2-propylpentanoic acid, valproate, or VPA), used both to treat
epilepsy and as a mood stabilizer in those with bipolar disorder (Roullet, Lai, & Foster,
2013), is a known teratogen, with multiple pregnancy registries confirming an increased
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risk of major congenital malformations and correlations to reduced cognitive abilities
following fetal exposure (Meador & Loring, 2013). Recently, connections have been
made between prenatal VPA exposure and ASD. In a population-based study of 655,615
children born in Denmark from 1996 to 2006, Christensen et al. (2013) found an
increased risk of ASD (absolute risk, 4.42%; adjusted hazard ratio, 2.9 [95% CI, 1.7-4.9])
and childhood autism (absolute risk, 2.50%; adjusted hazard ratio, 5.2 [95% CI, 2.710.0]) among the 508 children exposed to VPA (Christensen et al., 2013). Given the
connection between ASD and epilepsy (reported in approximately 1/3 of autism cases)
(Muhle et al., 2004; Tuchman, Cuccaro, & Alessandri, 2010), it is noteworthy that the
increased risk remained significant after adjusting for parental psychiatric disease and
epilepsy (Christensen et al., 2013; Meador & Loring, 2013).
Evidence from clinical studies indicating in utero exposure to VPA increases
ASD risk motivated researchers to develop an animal model of ASD (Roullet et al.,
2013). There is often uncertainty about the application of animal models to
social/cognitive disorders and mental illness. However, numerous independent studies
have successfully reported that the VPA animal model can be used to study the core
symptoms of ASD; the literature supports both high face and construct validity for
prenatal VPA treatment as an animal model of ASD (Roullet et al., 2013). Studies in both
rats and mice confirm that prenatal VPA exposure leads to autistic-like behaviors in
offspring, including social deficits, increased repetitive behaviors, and deficits in
communication (Roullet et al., 2013). In addition, VPA has been shown to cause delayed
physical development, reduced olfactory discrimination, and abnormal pre-weaning
social behavior in mice (Roullet, Wollaston, Decatanzaro, & Foster, 2010). VPA
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treatment in rodent models is also linked to reductions in Purkinje cell number and
cerebellar volume (Ingram, Peckham, Tisdale, & Rodier, 2000), decreased neuroligin 3
mRNA expression (Kolozsi, Mackenzie, Roullet, deCatanzaro, & Foster, 2009),
increased corticosterone and decreased immunological activity (Schneider et al., 2008),
and lower cortical expression of brain-derived neurotrophic factor (BDNF) mRNA
(Roullet et al., 2010), all of which are relevant to ASD.
As with ASD, there is evidence of sex differences in VPA exposure effects.
Prenatal VPA treatment in rats caused long-term, sex-specific effects on postnatal
behavior, including lower nociception reactivity, increased anxiety, and longer latency to
social behaviors in VPA males compared to VPA females; however, differences in
repetitive/stereotypic activity were similar in both sexes (Schneider et al., 2008). Mice
also display sex-dependent morphological changes, with both sexes showing decreased
Nissl-positive cell numbers in the prefrontal cortex, but only males displaying cell loss in
the somatosensory cortex following VPA exposure (Hara et al., 2012). In a series of
neurodevelopmental tests, mice exposed to VPA displayed timing differences in
development compared to controls, with sex differences observed in mid-air righting,
hanging wire grip strength, water maze, and motor activity (Wagner, Reuhl, Cheh,
McRae, & Halladay, 2006). In addition, mice exhibited social interaction deficits,
anxiety-like behavior and memory deficits; however, the social interaction deficits were
limited to male mice (Kataoka et al., 2013).
4.3 Maternal stress
Rodent models of maternal stress reveal how prenatal stress impacts the HPA axis
by increasing glucocorticoid secretion leading to structural changes in the brain
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(Weinstock, 2008). We know from clinical studies that prenatal maternal stress is
correlated with increased susceptibility to conditions such as ASD (Mueller & Bale,
2007, 2008), see section 3.3 for more detail. One mechanism by which perinatal stress
can cause sexually dimorphic responses is by altering the timing of HPG axis activation,
which would affect male gonad development and subsequent testosterone production.
Furthermore, numerous studies using rodent models also indicate increased male
vulnerability to cognitive and behavioral deficits, many of which are relevant to autism.
In a study of maternal stress in rats, repeated variable prenatal stress during the
third week of gestation produced deficits in object recognition, spatial reference,
conditioned fear, and object discrimination memory (Markham et al., 2010). In addition,
exposed male offspring were unable to gain competence on the novel object recognition
task and their ability to extinguish conditioned responses to tone in the fear conditioning
task was impaired, while prenatally stressed female rats were unaffected on these tasks
(Markham et al., 2010). Chronic maternal stress during the second half of gestation and
nursing in guinea pigs resulted in lower body weight and decreased activity in open field
for male offspring compared to controls, but there was no effect on body weight or
activity in female offspring; both males and females from stressed mothers, however,
displayed elevated basal salivary cortisol postnatally (Emack, Kostaki, Walker, &
Matthews, 2008). Mice dams were exposed to chronic variable stress in early, mid, or late
gestation; male offspring from dams exposed to early gestational stress showed
significant impairments in learning performance, while females exposed during the same
time period showed enhanced performance (Mueller & Bale, 2007). Early postnatal stress
resulting from chronic and unpredictable maternal separation (PD1-14) also produces sex
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differences; males reared under maternal stress displayed depressive-like behaviors in
forced swim and tail suspension tasks (Franklin et al., 2010). Moreover, the separated
male (but not female) pups had DNA methylation changes in the promotor regions of
several germline genes, which were transmitted across several generations resulting in
depressive behavior in offspring that were themselves reared normally (Franklin et al.,
2010).
Studies evaluating sex differences in genetic models of autism have primarily
failed to show sex differences in behavior, although differences in brain morphology and
physiology between the sexes have been found. Further research in additional models
involving targeted mutations of candidate genes is warranted. VPA and maternal stress
rodent models have been evaluated more thoroughly for sex differences, and both have
displayed more robust behavioral variations between the sexes, with VPA resulting in
increased nociceptor reactivity, anxiety, and decreased social behavior in males only, and
maternal stress inducing impairments in novel object recognition, fear conditioning,
learning performance, and increased depressive behaviors in males (but not females).
Both of these models strongly indicate increased male vulnerability to environmental
insults, producing cognitive and behavioral deficits such as increased anxiety, decreased
sociability, and increased depressive behaviors, which are relevant to ASD. Mechanisms
that increase male susceptibility in these areas appear to be conserved from rodents to
humans. These models provide a promising area of research to better understand the
mechanisms that contribute to this sex bias in vulnerability and its relevance to ASD.
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5. Conclusions
This review has compiled data from both clinical studies and animal models of
ASD with a focus on the sex bias and underscores the importance of ending the overrepresentation of males in autism research. While it is possible that current diagnostic
criteria fail to detect ASD in some high-functioning girls or that ascertainment bias
slightly overestimates the bias, the available evidence strongly indicates a sex difference
in ASD prevalence. In addition, clinical and basic research has found morphological,
physiological, and behavioral differences in the manifestation of the ASD phenotype
between the sexes. This body of work highlights the lingering uncertainty regarding the
mechanism responsible for this sex bias. Just as ASD is proposed to result from multiple,
variable factors, the sex bias in autism is likely the result of more than one factor that
either increases the vulnerability of males or protects females. Sex chromosomes,
parental imprinting, hormone exposure (gonadal or neurosteroidogenic), and
environmental mechanisms, such as increased parental age or maternal stress or immune
response, are current targets for further research. While animal models have limitations in
regards to human ASD pathology, they present valuable means to better understand the
relationship between genotype and phenotype and to evaluate aspects of environmental
exposures. Although recent work has shed light onto the exploration of the sex
differences in ASD, the collection of research presented here emphasizes the need to
better understand the mechanism(s) responsible for the sex differences.
6. Organization of Dissertation
This dissertation is focused on understanding the interaction of biological sex,
perinatal testosterone exposure, and behavioral and morphological pathologies associated
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with autism using a mouse model. A common theme in autism research is the multiple hit
hypothesis. Casanova (2007) proposed that ASD etiology includes (1) inheritance of
genetic susceptibility and (2) an environmental agent or endogenous stressor that (3)
occurs during a critical time period in brain development (Casanova, 2007), also known
as the triple hit hypothesis. Another 3-hit theory for contributions to ASD, developed by
Davis and Pfaff (2014), includes androgenic hormone effects as one of the hits (Davis &
Pfaff, 2014). As ASD is proposed to result from multiple, variable factors, the sex bias in
autism is likely the result of more than one factor that either increases the vulnerability of
males or protects females. In chapter two of this dissertation I establish baseline data
regarding sex differences in a wheel running assay designed to measure autism-like
behaviors, such as habit formation, cognitive rigidity, stereotypical behaviors, and social
interaction in 3 commonly used strains of developmentally normal mice. Chapter three
focuses on the effects of perinatal testosterone on behavior and brain morphology in a
mouse model of autism. Specifically, my work used a mouse model of autism to mimic
differential susceptibility of males and females to a prenatal insult, VPA, and to
determine whether masculinizing females perinatally with testosterone (T) following
VPA treatment will also masculinize their risk for abnormalities in brain development
and behavior relevant to ASD. Chapter four is a summary of the findings from my
dissertation research with possible future directions presented.

33

CHAPTER 2
INVESTIGATION OF PRE-PUBERTAL SEX DIFFERENCES IN WHEEL RUNNING
AND SOCIAL BEHAVIOR IN THREE MOUSE STRAINS
1. Introduction
To date, neuroscience research remains biased towards male animals, following
the assumption that cyclic sex hormones in females may confound results (Cahill, 2012).
A 2009 survey showed a male bias across research disciplines, with the ratio of maleonly to female-only studies in neuroscience at 5:1 and subject sex omitted in 22–42% of
articles (Beery & Zucker, 2011). More disturbingly, investigators often assert that
findings from male-only studies lead to conclusions that are applied to both sexes (Cahill,
2012). Researchers across disciplines now recognize the importance of considering sex
and sex differences in the design and interpretation of studies ("Putting gender on the
agenda," 2010). Recent suggestions include incorporating females and males in equal
numbers with a clear comparison of the two sexes (Prendergast, Onishi, & Zucker, 2014).
The classic Organizational-Activational Hypothesis proposed by Phoenix et
al.(1959), which states that gonadal hormones activate brain regions in adulthood
previously organized by those hormones early in development, has been expanded to
more accurately represent the complexities of sexual development. Sex differences in the
brain and behavior result from intricate interactions among steroid hormones synthesized
in both the gonads and the brain; sex chromosomes acting at the genetic, cellular, and
biochemical level; and the environment from early development throughout the lifespan
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(Lenz et al., 2012; Prendergast et al., 2014). Sex differences in the brain occur at many
levels, including differences in regional volume and/or cell number, morphology,
physiology, molecular signaling, and gene expression (Lenz et al., 2012), leading to
differences in learning and memory, fear, anxiety, and nociception (McCarthy et al.,
2012; Prendergast et al., 2014).
Mammalian species tend to exhibit sex differences in social behavior as adults,
especially those relating to mating and courtship; however, differences often extend
beyond obvious variations in mating behavior (Meaney, Stewart, & Beatty, 1985).
Previous studies have reported no apparent sex-related differences in general activity in
the mouse (Lamberty & Gower, 1988), nor an effect of estrous cycle on activity in adult
mice (Dowse, Umemori, & Koide, 2010; Meziane, Ouagazzal, Aubert, Wietrzych, &
Krezel, 2007). However, other evidence has linked sex steroids to wheel running
distance, speed, and duration in both sexes of adult mice (Bowen et al., 2012) and shown
that in the Hsd:ICR strain (outbred descendants of the Swiss-Webster strain), females
spend more time wheel running and at a faster speed than males (Swallow, Carter, &
Garland, 1998). These measures did not differ by sex in lines of mice selectively bred
from the Hsd:ICR strain for high wheel running activity (Garland et al., 2011).
In addition, many mammalian species display sex differences in social play of
juveniles. Generally, male rats are more likely to initiate and engage in play-fighting
behaviors than females, whereas females are more likely to withdraw from a play
initiation (Meaney et al., 1985). Although mice do not generally display ‘rough and
tumble play,’ other measures to assess social reciprocity and play include nose-to-nose
sniffing, anogenital sniffing, following, crawling over/under, and social grooming
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(Crawley, 2007). Unlike the mating/courtship behavioral differences seen in adult
animals, these social behaviors are seen pre-pubertally, i.e., before sexual maturity. Any
disparities seen in behavior at this stage are more likely due to the perinatal environment,
sex chromosomes or other prenatal effects than to differences in gonadal hormones
circulating at the time of the behavioral trial.
In order to effectively model behavioral disorders using animals of both sexes, it
is important to assess baseline sex-related behavioral differences, especially when
studying disorders for which sex-related behavioral effects are expected, such as autism.
The sex bias of autism has a male to female ratio of 4:1 and even higher in cases without
dysmorphic features and Asperger syndrome (Moldin & Rubenstein, 2006). Recent
research has stimulated the generation of animal models to better elucidate the role of
specific genes and environmental influences in the pathogenesis of autism (Oddi et al.,
2013).
Current neuroscience literature supports a variety of mouse behavioral assays
designed to maximize relevance to social deficits specific to autism (Silverman, Yang,
Lord, & Crawley, 2010). The results from previous studies using mouse models of autism
have underscored the importance of including age and sex as relevant factors (Oddi et al.,
2013). The strains chosen for this study were inbred (C57BL/6) and outbred (CFW and
CF1) mice, commonly used as general multipurpose models. On postnatal days 27-33,
we investigated the effect of sex on distinct behaviors. Using a series of running wheel
assays developed to evaluate autism-like behaviors (Karvat & Kimchi, 2012), we
measured the animals’ ability to gain and maintain a routine, assessed repetitive behavior,
evaluated cognitive rigidity and examined social interactions. This behavioral array was
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chosen because of its relevance to the core symptoms of autism and in preparation for
future work assessing autism-like behaviors following developmental insults. Examining
the animals before puberty should reduce behavioral variations due to circulating sex
hormones. By assessing three mouse strains, we attempted to find information that
applies more generally to the species, rather than to only one strain. Most importantly,
these assays provide needed insight into pre-pubertal sex-related differences in behavior.
2. Materials and Methods
2.1 Animals
The animals used in this study were 3 strains of mice: C57BL/6 (n=16; 8 males
and 8 females), CFW (n=24; 12 males and 12 females), and CF1 (n=20; 10 males and 10
females). The mice were received from the vendor (C57BL/6, Jackson Laboratory; CFW
and CF1, Charles River) at approximately 3 weeks of age (P20-P21). Initial body weights
were taken on the day of arrival, which was P20 for C57BL/6 and P21 for CFW and CF1.
All animals were maintained in our animal facility on a 12:12 light/dark cycle and were
provided with TekLad 2016 rodent chow and tap water ad lib. The C57BL/6 mice
remained on their previous light schedule (lights off 6pm), while the CFW and CF1 mice
underwent a phase shift to correspond with the researchers’ schedule. On day one lights
went off at 6pm. On day 2 the mice underwent a 3 hour phase shift, with lights off at
3pm. The CFW mice underwent another 3 hour shift on day 3 resulting in lights off at
12pm (note that daylight savings time started immediately after this shift so that the lights
actually went off at 1pm during trials), whereas the CF1 mice underwent a 2 hour shift on
day 3 resulting in lights off at 1pm. The light schedule on subsequent days was
maintained. Within each strain, two mice of each sex were housed separately to be used
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for social testing purposes only; in CFW and CF1 strains these mice were also shipped
separately. After a week-long acclimation period, the experimental animals were tested
with a series of wheel-running assays (see section 2.2). Euthanasia was performed
following a standard protocol of intracardial perfusion with 4% paraformaldehyde; final
body weights, testis and uterine weights were taken at this time to assess growth and
sexual maturity. The C57BL/6 mice of both sexes were perfused in two groups on
postnatal days 34 and 35. All CFW and CF1 females were perfused on postnatal day 33,
while all males were perfused on postnatal day 34. Animal care provided was in
accordance with the Guide for the Care and Use of Laboratory Animals (Guide for the
Care and Use of Laboratory Animals, 2011) and procedures were approved by our
Institutional Animal Care and Use Committee. Note: The trials for each strain were
completed independently so that only one strain of mice was housed and tested at a time.
2.2 Test Procedure
Animals were tested during the dark phase of the light cycle to ensure they were
in their most active period when tested. Video was collected using a camera with nightvision capability under red lights. The wheel-running assays used a plexiglass cage (34.5
cm x 23 cm x 19 cm, covered) lined with corncob bedding and fitted with a standard
plastic mouse running wheel (14 cm diameter) that either freely turned or was jammed by
a metal pin. To remove olfactory cues, the layer of bedding was changed and the entire
cage was cleaned with 70% ethanol between trials. We followed the protocol of Karvat &
Kimchi (2012) to assess wheel running behaviors. Modifications were made to assess sex
differences in behavior, as specified subsequently. Stage 1: gaining and maintaining a
routine. For the C57BL/6 strain each mouse was placed in the cage for 20 minutes and
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permitted to run on the wheel freely for 4 consecutive days; the trial time was reduced to
15 minutes and period reduced to 3 consecutive days for CFW and CF1 strains, as
analysis of C57BL/6 data revealed this timing should be sufficient for routine wheel
running to be established. Stage 2: repetitive behavior. Each mouse was recorded for 15
minutes in the cage with the wheel jammed on days 5-6 (for C57BL/6) or days 4-5 (CFW
and CF1). For each sex, time spent grooming and burrowing in the bedding on days the
wheel was free (1-4 or 1-3) and on days the wheel was jammed (5-6 or 4-5) was assessed.
Stage 3: cognitive rigidity. Cognitive rigidity is defined as the inability to forgo a
habit/routine. Time spent interacting with the wheel when it was jammed was measured
and evaluated for sex-related differences in cognitive rigidity. Stage 4: social interaction.
On day 7 (C57BL/6) or day 6 (CFW and CF1) each study mouse spent 10 minutes in the
cage with the jammed wheel and an age and sex-matched novel mouse. The novel mouse
was placed into the cage first, followed by the study mouse to allow the observer to
identify the mice and score behaviors accordingly. We tested for social interaction by
assessing the time spent by the study mouse engaging in social investigation with a novel
mouse. Contact and following behaviors were assessed for differences in social behavior
between the sexes.
2.3 Scoring
Behavior scores were recorded using the Noldus Observer software version 4.1.
For all days, the following items were measured: latency to begin wheel running;
directionality and duration of wheel running; interaction with wheel without movement
(i.e., sitting on wheel), and duration of burrowing, grooming, and interaction with the
cage’s water nozzle. For durations, percentage of total trial was used instead of time,
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because the total time differed among strains. Burrowing was scored when pieces of the
bedding were intentionally moved by the mouse. On the days the wheel was jammed,
“wheel running” was scored as interaction of the mouse with the wheel that would have
made the wheel move if it were free. Time the mouse spent on top of the jammed wheel
was excluded from the wheel interaction score. On the final day, interaction of the study
mouse and a novel, age and sex-matched mouse provided information on sociability. Any
physical engagement between the mice, whether initiated by the study mouse or by the
novel mouse, was scored as social interaction, divided into contact and following
behaviors.
2.4 Statistics
Running wheel assays (i.e., latency and duration of wheel running and
stereotypical behaviors) were analyzed for sex, day and sex x day interactions in SAS
(9.3, SAS Institute Inc.) using a mixed linear model with the restricted/residual maximum
likelihood (REML) estimation method. The Kenward-Roger approach was used to
approximate inference about fixed effects to estimate denominator degrees of freedom in
tests for fixed effects. Day and sex x day were specified as random effects. Data were
transformed as appropriate to reach normality: for C57BL/6 data the square root was
taken for the duration of wheel running and interaction with the water nozzle, and for the
latency to wheel run; for CFW the duration of wheel running data was squared, the
square root was taken for duration grooming data and the natural log was taken for
duration of interaction with the water nozzle; for CF1 the duration of wheel running data
was squared, while the square root was taken for latency to wheel run. To adjust for the
number of simultaneous tests to assess the effect of day, the sequential Bonferroni test
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was used (Rice, 1988). The latency and duration of contact and following behaviors of
the study mouse with a novel mouse were analyzed by t-test with sex as an independent
variable. Strain differences in wheel running duration was analyzed by one-way ANOVA
with pairwise multiple comparisons made using the Holm-Sidak method. Because we
found no significant sex differences within each strain, this analysis combined data for all
mice of a given strain.
3. Results
In all 3 strains (C57BL/6, CFW and CF1), pre-pubertal mice follow patterns of
wheel running behavior characteristic of normal adult mice, with some differences among
strains; however, there are not significant differences in wheel running behaviors between
the sexes at this age.
3.1 Latency of Behavior
In a typical animal gaining a routine, latency to run should decrease following the
initial introduction to the novel wheel. The mixed model analysis for latency to begin
wheel running revealed a significant effect of day for analyses of days 1-6 for C57BL/6
(p<0.0001) and days 1-5 for CFW (p<0.0001) and CF1 (p=0.0002) (Fig 1, A-C). For days
the wheel was free, latency to run was significantly less on day 2 compared to day 1
across all strains (p<0.0001), displaying appropriate routine gaining. Cognitive rigidity is
evaluated by the inability to forgo a routine. Latency to run increased on the second day
the wheel was jammed as compared to the first (p<0.001 for all strains), suggesting that
the mice in our study remembered the wheel was jammed the previous day and could
adjust their routine. We found no significant difference in latency to run on the wheel
between males and females across days for C57BL/6, CFW, or CF1 (p=0.3304,
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p=0.9399, p=0.5988, respectively). The observer noted that C57BL/6 males were more
inclined to explore the cage on day one and appeared to initiate wheel running later than
C57BL/6 females. The mean latency to run on the wheel for females was 159.8 ± 11.2
seconds and for males was 238.8 ± 40.0 seconds; however, the latency data across all
days failed to reach statistical significance for sex (p=0.3304) and there was no
significant sex x day interaction (p=0.4062). Social behavior was demonstrated by the
latency of the study mouse to initiate contact or begin following the novel mouse. For all
strains, t-tests indicated there was no difference between sexes in latency to contact or
follow the novel mouse (Fig 2, A-B) (p=0.134 to p=0.942).
3.2 Duration of Behavior
The percentage of trial duration spent wheel running was also analyzed using a
mixed effects model in SAS (Fig 1, D-F). Duration analysis again revealed a significant
day effect during days 1-6 for C57BL/6 (p<0.0001) and days 1-5 for CFW (p<0.0001)
and CF1 (p<0.0001). Total duration of wheel running increased across days the wheel
was free; however, interaction with the wheel dropped for days when the wheel was
jammed. In a comparison of wheel running duration on day 1 (first day free) vs. day 4/3
(last day free) and also day 5/4 (first day jammed) vs. day 6/5 (second day jammed), all
p-values reached significance (p<0.0003 for all comparisons) using the Bonferroni
adjustment, except CFW day 1 vs. day 3. This follows the expected pattern of behavior
for animals lacking rigidity to change habits, i.e., a normal mouse should decrease its
interaction time with the wheel on the second day that the wheel is jammed, which was
apparent on day 6/5. We found no significant difference in percentage duration of wheel
running between the sexes across days for C57BL/6, CFW, or CF1 (p=0.6146, p=0.1674,
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p=0.4881, respectively). However, there were strain differences in percentage duration of
wheel running for the last day the wheel was free (p<0.001), first day the wheel was
jammed (p=0.001), and second day the wheel was jammed (p<0.001) (Table 1). Total
duration of contact and following behaviors with the novel mouse were examined from
the social interaction test (Fig 2, C-D). The t-tests indicated no significant differences
between sexes in contact or following behaviors of the study mouse with a novel mouse
(p= 0.114 to p=0.866)
We also evaluated the total duration percentage of stereotypical behaviors, such as
burrowing, grooming, and interaction with the water nozzle. The ability to freely run on a
wheel reduces stereotypical behaviors, e.g., burrowing in bedding (Karvat & Kimchi,
2012). Therefore, a typical animal should spend more time performing stereotypical
behaviors when the wheel is jammed vs. free. We compared these behaviors for the last
day the wheel was free (day 4/3) vs. the first day it was jammed (day 5/4), and found that
grooming and water nozzle interaction were displayed more often when the wheel was
jammed (p<0.0003 for all strains). The inability to run on a wheel increased these
stereotypical behaviors in both sexes. A day effect was noted for grooming behaviors in
both CFW and CF1 strains (CFW p<0.0001, CF1 p=0.0042) (Fig 3, E-F). Statistical
analysis of grooming in C57BL/6 mice was hindered by its infrequency in this strain, yet
these animals displayed the same pattern of behavior as seen in other strains (Fig 3, D). A
day effect of interaction with the water nozzle was displayed across all days (p<0.0001
for all strains) (Fig 3, G-I). Burrowing was exceedingly rare while the wheel was free and
represented a small percentage of time spent on days the wheel was jammed (Fig 3, A-C;
Fig 4). A sex effect was seen for water nozzle interaction in CF1 mice across all days, in

43

that males were more likely to interact with the nozzle than females (p=0.0263), but not
in any other strain (p=0.3143 and p=0.5966). In addition, brief mutual grooming was
displayed in both sexes during the social interaction trial. Both sexes displayed similar
patterns of behavior in that they were more likely to interact with the wheel when it was
free and performed other behaviors when it was jammed. See Figure 4 for a
representation of total duration of all behaviors by sex and across days. Three days are
shown for each sex from all strains: the last day the wheel was free (left column) and the
subsequent two days when the wheel was jammed. This figure clearly displays our main
findings: within each strain there was a lack of sex differences in behavior; however,
strain differences in wheel running behavior were apparent (analysis in Table 1).
3.3 Morphology
Mouse morphology data, including body and gonad/uterine weight, can be found
in Fig 5. The weights of both CFW and CF1 mice matched expected growth curves
(Charles River Laboratories International Inc., 2014a, 2014b); C57BL/6 mice were above
the expected weight at 3 weeks, but matched published growth curve weights by 5 weeks
(The Jackson Laboratory, 2014).
4. Discussion
Wheel running is widely studied in rodents (Novak, 2012), as it appears to be a
highly rewarding activity (Werme et al., 2002). Karvat and Kimchi (2012) used this
instinctive wheel running propensity in mice to develop a behavioral test relevant to
autism-like behaviors. It assesses key features including rigidity to change habits,
repetitive stereotypical behaviors and impaired social interactions. We used this
technique to evaluate sex differences in these behaviors in pre-pubertal mice. Overall, we
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found no significant sex differences in wheel running behaviors in 3 strains of prepubertal mice.
In adult rats, assessments of wheel running have repeatedly shown higher levels
of activity in females (Beatty, 1992), and also shown that wheel running activity is
variable along the estrous cycle (Kent, Hurd, & Satinoff, 1991). Some studies of general
activity and wheel running in adult mice have reported sex differences (Broida & Svare,
1984; Garland et al., 2011; Swallow et al., 1998), while others have not (Lamberty &
Gower, 1988). Sex steroids do appear to influence wheel running in adult C57BL/6 mice,
in which females exhibit greater activity (i.e., distance and duration) than males at
baseline; gonadectomy significantly reduced levels of wheel running (distance, duration,
and velocity) in both males and females, which was at least partially recovered upon
steroid replacement (Bowen et al., 2012). In addition, control Hsd:ICR mice showed sex
differences in wheel running measures, including minutes per day and revolutions per
day, and sex differences approached significance in average velocity (Garland et al.,
2011). However, another study using C57BL/6 found no effect of estrous cycle on
general activity in the open field assay (Meziane et al, 2007). With no previous data on
pre-pubertal wheel running in mice, we explored the possibility of sex differences, which
could result from differences in neural structure/circuitry of the sexes established
perinatally. The similarity in wheel running behavior provides further evidence that
wheel running behaviors may be linked to circulating sex steroids and differences only
emerge after hormone levels increase following puberty. On the other hand, it is also
plausible that a pre-pubertal sex difference in this behavior exists, but the sensitivity of
the behavioral test may be inadequate to detect a difference between males and females
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(Kelly, Ostrowski, & Wilson, 1999). It is worth noting that two of the strains underwent
photoperiod phase shifting in the week before testing; however, this did not have
noticeable effects on behavior in this assay, which was done in the dark phase for all
strains.
We also found a lack of variability in social behaviors between the sexes. There
were no significant sex differences in contact or following behaviors of the study mice
with the novel mice. While it should be noted the study and novel mice used in the
C57BL/6 strain were shipped in the same container prior to being separated for 13 days
before the social interaction test, the study and novel mice in the other strains were
shipped and housed separately to maintain novelty. Similar results were found across all
strains for both contact and following behaviors. Social grooming, self-grooming, noseto-nose sniffing, ano-genital sniffing, following and exploratory activity were exhibited
by both sexes.
Another factor that was inherent to our study is the timing of puberty. Since the
mice were not reared onsite, they were received following weaning around 3 weeks of
age. Mice were given a week-long acclimation period, followed by the 6-7 day wheelrunning assay. Perfusions were then performed between postnatal days 33 and 35.
Puberty is the transitional period prior to adulthood that terminates with the production of
mature gametes and the start of reproductive activity (Mayer et al., 2010). Sexual
maturity is usually reached in females with the onset of estrus between 40-51 days,
depending on weight and other environmental conditions (Pinter, 2007). Uterine weight
and morphology are standard measures of estrogen action in immature female rodents
(Evans, 1941). The timing of puberty in males is suggested to begin around day 40
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(Albert, 1984). Considering the age of the animals, we can be relatively confident that
our study was conducted before either sex reached sexual maturity. The variability in
uterus weights suggests that some females might have been further along in puberty than
others (Fig 5, C). Puberty occurs over time with the onset of neuroendocrine events that
stimulate the pulsatile release of GnRH, which activates the pituitary/gonadal axis and
directs gonadal steroid hormone production and the maturation of gametes (Colledge,
Mei, & d'Anglemont de Tassigny, 2010; Mayer et al., 2010). Considering that increased
gonadal hormone activity begins prior to sexual maturity at the conclusion of puberty, we
cannot be certain that all animals were tested before the initiation of increased
gonadotropic activity. However, with behavioral trials completed prior to P33 the
influence of circulating gonadal hormones should have been minimal.
Both sexes showed characteristic wheel running behavior, spending the majority
of each trial interacting with the wheel when it was free and more time performing other
activities (e.g., stereotypical behaviors, general locomotion) when it was jammed. Given
that sex differences were not detected in this assay, the results show that baseline prepubertal sex-related differences are not strong enough to influence behavior in runningwheel studies. Furthermore, the inclusion of three strains provides evidence that these
results apply more generally to the species, rather than to only one strain. We found
differences among strains, including duration of time spent wheel running (or attempting
to run) when it is both free and jammed. Interestingly, sex differences in wheel running
have been found in adult mice related to two of our strains (C57BL/6: Bowen et al, 1992;
CFW and Hsd:ICR both descend from same Swiss-Webster stock: Swallow, Carter, &
Garland, 1998), but we found no sex differences within any of our tested strains before
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sexual maturity. We conclude that sex-related behavioral differences can be discounted
when designing future experiments to measure the effects of developmental insults on
wheel running behavior in juvenile mice. Therefore, if sex differences in the runningwheel assay emerge after a developmental insult, one can make inferences regarding
relative susceptibility of males vs. females to that treatment.
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Table 1: Strain differences in duration of wheel running (mean % + SEM) on last day
free (Last Free), first day jammed (Jammed 1), and second day jammed (Jammed 2).
Strain

Last Free

Jammed 1

Jammed 2

C57BL/6

69.9 + 2.96a

16.6 + 0.73b

4.9 + 0.48a

CFW

55.0 + 1.86b

13.6 + 0.63a

2.3 + 0.52b

CF1

69.0 + 2.71a

12.1 + 0.84a

7.7 + 0.50c

abc

Differing superscripts in a given column indicate statistically significant difference (p

< 0.05) across strains in % duration wheel running (or attempt to run in wheel when
jammed) for that column. Males and females did not differ within strains for this measure
(Fig 1, D-F), so are both included in this analysis.
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Fig. 1. Wheel running behavior. (A-C) Latency of mice to run on wheel (mean sec ±
SEM). A) C57BL/6, B) CFW, C) CF1; (D-F) Duration of wheel running (mean % total
trial ± SEM). D) C57BL/6, E) CFW, F) CF1. * = first day the wheel was jammed. When
the wheel is jammed, “wheel running” is defined as any activity that would make the
wheel move if it were free.
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Fig. 2. Social behaviors. (A-B) Latency of social interaction with novel mouse (mean sec
± SEM), analyzed for sex differences within strains. A) contact, C57BL/6, p=0.215;
CFW, p=0.134; CF1, p=0.447. B) follow, C57BL/6, p=0.765; CFW, p=0.942; CF1,
p=0.595. (C-D) duration of social interaction with novel mouse (mean % total trial ±
SEM). C) contact, C57BL/6, p=0.548; CFW, p=0.114; CF1, p=0.495. D) follow,
C57BL/6, p=0.817; CFW, p=0.770; CF1, p=0.866.
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Fig. 3. Duration of sterotypical behaviors (mean % ± SEM). (A-C) burrowing: A)
C57BL/6, B) CFW, C) CF1; (D-F) grooming: D) C57BL/6, E) CFW, F) CF1; (G-I) water
nozzle interaction: G) C57BL/6, H) CFW, I) CF1. * = the first day the wheel was
jammed.
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Fig. 4. Duration (mean %) of all behaviors by sex and day. Note: WhInt, running or
sitting on wheel; H2ONozzle, interact with water nozzle; Other, includes cage
exploration and climbing on top of jammed wheel.
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Fig. 5. Mouse morphology. A) Female initial and final body weight (g) by strain (mean ±
SEM), B) Male initial and final body weight (g) by strain (mean ± SEM), C) Scatter plot
of uterine weights (g), D) Scatter plot of paired testes weights (g). Note: Uterine weights
were not collected for C57BL/6.
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CHAPTER 3
EVALUATING SEX DIFFERENCES AND THE EFFECT OF PERINATAL
TESTOSTERONE IN A MOUSE MODEL OF AUTISM
1. Introduction
Autism Spectrum Disorders (ASD) are heterogeneous, behaviorally defined
conditions characterized by impairments in social interaction, communication, and
limited range of interests and activities (Muhle et al., 2004). The prevalence of this
disease has been on the rise over the last decade (Center for Disease Control and
Prevention, 2016). In many cases the cause of ASD is unknown, with numerous causal
mechanisms under investigation, but most researchers agree that autism is a multifactorial
condition (Casanova, 2007; Rutter, 2005). ASD is heavily biased towards males
(Auyeung et al., 2010), with ratios ranging from 4:1 for classic autism to 11:1 in
individuals with Asperger Syndrome (Baron-Cohen et al., 2011). Research into the
reasons for this disparity has been limited, but tends to focus on factors that could
increase vulnerability in males or, conversely, are protective in females (Alycia K.
Halladay, 2015; Baron-Cohen et al., 2011). A common theme in autism research is the 3hit or triple hit hypothesis (Casanova, 2007; Davis & Pfaff, 2014). As ASD is proposed to
result from multiple, variable factors, the sex bias in autism is likely the result of more
than one factor that either increases the vulnerability of males or protects females. Using
a modified triple hit design, we aimed to determine if prenatal exposure to an ASDinducing teratogen during a vulnerable developmental window, maleness, and additional
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testosterone produced a more severe ASD-like phenotype in mice than those with fewer
hits.
Baron-Cohen and colleagues developed the Extreme Male Brain (EMB) Theory,
suggesting that ASD is the result of an over-expression of psychological/physiological
properties of the male brain, implying males are more likely to display the ASD
phenotype (Baron-Cohen et al., 2011). Recent evidence suggests the EMB phenotype
could result from elevated levels of steroidogenic activity, including fetal testosterone
(fT) (Baron-Cohen et al., 2014), rather than an androgen receptor abnormality or sexually
dimorphic gene expression unrelated to fT (Baron-Cohen et al., 2005). Other conditions
resulting in abnormal prenatal hormone levels suggest elevated androgens during fetal
development could play a role in ASD etiology. Congenital adrenal hyperplasia (CAH),
which causes elevated prenatal adrenal androgen production, results in higher scores on
the autism-spectrum quotient (AQ) and lower vocabulary scores in females with the
condition compared to unaffected female siblings (Knickmeyer et al., 2006). Mothers
with polycystic ovary syndrome (PCOS) resulting in abnormally high blood testosterone
during pregnancy, produced children with higher total AQ scores compared to controls,
with some measures only reaching significance in daughters (Palomba et al., 2012).
Multiple studies have correlated fT levels from amniotic fluid samples with ASD
indicators, such as autistic traits, restricted interests, poorer quality social relationships,
and reduced empathy (Auyeung et al., 2010; Chapman et al., 2006; Knickmeyer et al.,
2005). Despite formulation of several testable hypotheses, the underlying cause for the
sex bias remains undetermined (Auyeung et al., 2012).
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Fetal exposure to valproic acid (VPA, 2-propyl-pentanoic acid), a drug used in the
treatment of epilepsy and bipolar disorder (Roullet et al., 2013), was found to increase
risk of major congenital malformations and reduce cognitive abilities (Meador & Loring,
2013), as well as increase risk of ASD (Christensen et al., 2013). VPA acts to increase
gamma-aminobutyric acid synthesis and availability (Dufour-Rainfray et al., 2010;
Loscher, 1999) and as a histone deacetylase inhibitor, providing a mechanism to
influence gene expression (Dufour-Rainfray et al., 2010). The association between VPA
and ASD prompted researchers to develop exposure to VPA as an animal model of ASD
(Roullet et al., 2013). Multiple studies in rodents have found that prenatal VPA exposure
leads to ASD-like behaviors, including increased repetitive behaviors, delayed physical
development, reduced olfactory discrimination, poorer social interaction, increased
anxiety, and deficits in ultrasonic vocalization (Kataoka et al., 2013; Roullet et al., 2013;
Roullet et al., 2010). In addition, VPA treatment in rodents is associated with decreased
cerebellar volume and Purkinje cell number (Ingram et al., 2000), reductions in
neuroligin 3 mRNA (Kolozsi et al., 2009) and brain-derived neurotrophic factor (BDNF)
mRNA expression (Roullet et al., 2010), and increased corticosterone levels and
diminished immunological activity (Schneider et al., 2008). Sex differences in postnatal
behavior and neural development have been reported in VPA treated rodents, wherein
males display reduced nociception reactivity, heightened anxiety, social interaction
deficits (Kataoka et al., 2013; Schneider et al., 2008), delayed motor development
(Wagner et al., 2006), and cell loss in the somatosensory cortex (Hara et al., 2012).
With numerous studies providing evidence of correlations among elevated fT,
brain development, and the ASD phenotype, further investigation into this link was
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warranted (Gore et al., 2014). A better understanding of the relationship among
testosterone, ASD risk, and sex can be gained from a direct manipulation of perinatal
testosterone (pT). Because prenatal VPA causes sex-specific differences in both behavior
and morphology, it was utilized as the autism-inducing insult in this study. Using a
modified triple hit design, we sought to determine if prenatal exposure to VPA during a
vulnerable developmental window, maleness, and increased testosterone produced a more
severe ASD-like phenotype in mice than those with fewer hits. This will allow us to
better understand sex differences in VPA effects on brain morphology and behavior and
to determine if pT’s masculinization/de-feminization properties increase female
vulnerability to the ASD-inducing insult.
2. Materials and Methods
2.1 Animals
Animal care was in accordance with the Guide for the Care and Use of Laboratory
Animals: Eighth Edition (NRC 2011) and procedures were approved by our Institutional
Animal Care and Use Committee. Swiss Webster (CFW) mice were purchased from
Charles River Laboratories across 3 separate cohorts in late 2015 and early 2016. This
strain was selected because it is commonly used as a general multipurpose model and was
used in our previous work investigating sex differences in an autism-relevant wheel
running assay (Gordon & Corbitt, 2015). The mice were received from the vendor at
approximately 8-10 weeks of age and housed separately by sex during a week-long
acclimation period. All animals were maintained in our animal facility on a 12:12
light/dark cycle and were provided with TekLad 2016 rodent chow and tap water ad lib.
Following the acclimation period, we paired two dams with each sire and housed them
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together for breeding. The first day of gestation (E0) was determined based on the
presence of a mating plug, at which point dams were separated from sires and housed
singly for the remainder of gestation.
We used a between-litter treatment (VPA) and a within-litter treatment
(testosterone propionate, TP), see Table 1. Pregnant dams were injected with either 500
mg/kg VPA in saline (i.p.) or vehicle alone (Veh1) on day E12.5 (Hara et al., 2012;
Kataoka et al., 2013). Fourteen pregnant dams were separated across 3 cohorts; cohort 1
had only 3 pregnant dams due to VPA litter resorption, cohort 2 had 6 dams, and cohort 3
had 5 dams. Day of birth was noted as postnatal day 0 (P0), at which point we counted
pups and checked for stillbirths. On postnatal day 1 (P1), ano-genital (AG) distance was
measured and a 2 mm tail clip was taken after analgesia for Sry detection via PCR,
protocol modified from Meeker et al. (2007), in order to identify the sex of each pup. In
addition, the animals were weighed and marked with permanent marker as a temporary
identifier. On P2, each pup was given a unique tattoo mark using Ketchum animal tattoo
paste and a 25 gauge needle for identification throughout the remainder of the project.
Following an unusually large litter of 15 pups in cohort1 that had to be excluded, all
litters were culled to 10 pups on P2 for cohorts 2 and 3. Approximately half of the
offspring (divided equally by sex) from each litter received 100 μg TP in 25 μl peanut oil
(s.c.), while the others received peanut oil vehicle only (Veh2). Note that TP was
administered on postnatal day 2 because the critical period when male rodents produce
testosterone occurs immediately after birth, rather than prenatally as in humans (Hines,
2006). The within-litter and between-litter treatments can also be thought of in
accordance with previous “3-hit” or “multiple-hit” hypotheses of autism etiology
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(Casanova, 2007; Pfaff, Rapin, & Goldman, 2011; Schaafsma & Pfaff, 2014), wherein in
our study the hits are 1)VPA treatment, 2) TP treatment, and 3) “maleness.” Hence, a
VPA-TP treated male would be considered to have 3 hits, while a Veh1-Veh2 treated
female would have 0 hits. All offspring underwent behavioral testing (see section 2.2)
and were used for brain measures (see section 2.3). Some males and females from the
Veh1 litters that also received Veh2 were used as novel mice in sociability testing; since
these novel mice underwent multiple rounds of social exposure, they were not used to
measure sociability.
Following the behavioral testing (P31), 80 mice from all cohorts underwent
intracardial paraformaldehyde perfusion following standard protocols for morphological
endpoints. A small sample of 16 mice from cohort 3 was decapitated under full
anesthesia and their brains collected for a separate study.
2.2 Behavioral Testing
We selected our behavioral tasks to be relevant to cerebellum (Cb) impairment
and the core behavioral deficits associated with ASD. The motor development tests
assess delays resulting from VPA’s effect on Cb morphology; other studies have shown
deficits in motor development following prenatal VPA treatment in mice (Wagner et al.,
2006). The open field and elevated plus maze measure general locomotion, which may be
influenced by Cb development, along with anxiety-like behavior, which has shown to be
increased following VPA treatment (Kataoka et al., 2013; Mehta, Gandal, & Siegel,
2011; Schneider et al., 2008) and is common in ASD (White, Oswald, Ollendick, &
Scahill, 2009). Karvat and Kimchi (2012) used the instinctive wheel running propensity
in mice to develop a wheel running assay (WRA) relevant to autism-like behaviors
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(Karvat & Kimchi, 2012). It assesses key features of ASD including rigidity to change
habits, repetitive stereotypical behaviors, and impaired social interactions. In our
previous work we showed no baseline sex differences on measures of the WRA in prepubertal mice (Gordon & Corbitt, 2015), but differential vulnerability to VPA could
induce sex differences. Using the VPA rodent model, others have shown increased
repetitive behaviors and social interaction deficits (Gandal et al., 2010; Mehta et al.,
2011; Schneider et al., 2008), which are assessed using the WRA.
Motor development tests. The mice underwent a series of tests to assess motor
development, including surface righting, mid-air righting, negative geotaxis, and hanging
grip strength (Wagner et al., 2006). For the surface righting test on P3–8, pups were
placed on their backs and the time taken to turn over to all four paws was recorded. If
animal did not right itself in 30 s, this time was recorded. For the mid-air righting on days
P13–19, pups were held with ventral side up then released 30 cm above a foam pad.
Ability to right was scored if the pup landed on all four paws. Three attempts were given
each day to produce possible scores ranging 0 – 3 each day. The hanging grip strength
task was also performed on P13-19; mice were suspended by all paws grasping a wire
mesh placed horizontally 30 cm above a foam pad. The time spent hanging before
dropping to the pad was recorded for the grip strength test with a maximum of 60 s for
each trial. Tests were modified from Wagner et al. (2006). Mice were weaned on P21 and
separated by sex, at which point they were housed with littermates, up to 5 per cage.
They were given one day to acclimate to new housing before continuing with behavioral
trials on P23.
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Open field test/Elevated-plus maze. These tests were used to measure general
locomotion, activity, and anxiety-like behavior (Gandal et al., 2010; Kataoka et al., 2013;
Schneider et al., 2008). For the open field test (P23), mice were placed in a well-lit novel
black plexiglass cage (37 cm × 37 cm × 37 cm) with overhead camera for 5 min. The
parameters measured using EthoVision® 3 Pro software (Noldus Information
Technology) included: distance traveled, velocity, and time spent in central vs edge
zones. The cage was cleaned with ethanol between mice to remove odor cues. The
elevated plus maze has four arms (10 cm x 50 cm) placed at 90° angles and mounted ~50
cm off the ground. Two of the opposite arms are enclosed by walls, while the other 2
arms remain open to light. Each mouse was placed in the center of the maze and then
recorded with an overhead camera for 5 min. The amount of time spent in closed vs. open
arms and the number of times entering open arms were the primary measures, but
distance traveled and velocity were also measured using EthoVision® 3 Pro software as
general locomotor indicators. The maze was cleaned with ethanol between mice to
remove odor cues.
Wheel running assays. The wheel running assays, modified from Karvat &
Kimchi (2012), assess routine gaining and maintenance, cognitive rigidity, repetitive
behaviors, and social interaction with a novel age and sex-matched mouse (Karvat &
Kimchi, 2012). These assays were performed over 6 days (P25-P30) and used a
plexiglass cage (34.5 cm x 23 cm x 19 cm, covered) lined with corncob bedding fitted
with a standard plastic mouse running wheel (14 cm diameter) that either freely turned or
was jammed by a metal pin; the layer of bedding was changed and the entire cage cleaned
with ethanol between mice. An observer blind to treatment group assessed the following
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using Noldus Observer software version 4.1. Stage 1: gaining and maintaining a routine.
Each mouse spent 15 minutes in the cage; latency to begin and duration of wheel running
were measured each day for 3 days. Stage 2: repetitive behavior. Time spent digging in
the bedding/grooming was compared for days the wheel was free vs. jammed. Stage 3:
cognitive rigidity. Time spent interacting with the wheel when it was free (days 1-3) and
when it was jammed (days 4-5) was measured. Stage 4: social deficit. Lastly, we tested
for social deficits by comparing the time spent by the study mouse with the jammed
wheel versus engaging in social investigation with a novel mouse (same cohort and sex as
focal mouse, but from different litter) on day 6. The novel mice were place into the arena
first; the study mice were then introduced. Only mice from Veh1 litters that also received
Veh2 were used as social mice; because they had been exposed to the social test for other
litters, these mice were not included in social trials for their own litters.
2.3 Brain Measures
Measures of brain development focused on the Cb because it is the brain area
most often affected in ASD (Wang, Kloth, & Badura, 2014). Cerebellar volume
differences are common in autistic patients, frequently with reduced Purkinge cell
numbers (Casanova, 2007; Palmen, van Engeland, Hof, & Schmitz, 2004). VPA rodent
models also show reductions in Purkinje cell number and Cb volume (Ingram et al.,
2000), but there are no published data regarding sex differences in the Cb following VPA
treatment. Brain development studies focused on regional volumes of the Cb, as this is
affected in both ASD (Casanova, 2007; Palmen et al., 2004) and VPA rodent models
(Ingram et al., 2000). Following perfusion, brains were removed and placed in fixative
(4% paraformaldehyde) then transferred through graded sucrose solutions prior to rapid

65

freezing using dry ice. The samples were stored separately at -80°C until further
processing. Each brain was sectioned sagitally at a thickness of 50 µm using a cryostat,
mounted onto SuperFrost Plus slides, followed by Nissl staining using thionin.
Stereological techniques were used to calculate regional volumes (Gundersen, Jensen,
Kieu, & Nielsen, 1999) using ImageJ software. Cerebellar volume was determined using
the Cavalieri principle, in which cross sectional area (mm2) was multiplied by distance
between sections to determine volume (mm3) and all sections were added (Gundersen et
al., 1999). The Cb hemisphere and the vermis were measured separately, as Ingram et al
(2000) previously found that prenatal VPA had a larger effect on vermis than on Cb
hemisphere in rats.
2.4 Statistics
We analyzed results of the study by number of hits and treatment group. Results
of all behavioral tests and brain measures were analyzed with a generalized, randomized,
block design (GRBD) using a mixed linear model in SAS (9.3, SAS Institute Inc.) where
each cohort was designated a ‘block’ or whole plot factor and the number of hits and
litter represented subplot factors. In an attempt to more clearly identify which treatments
were contributing to effects, a mixed linear model analysis was also run using the GRBD
with cohort as the whole plot factor and the treatments represented as subplot factors.
Between-litter treatment was one factor with two variables: VPA or Veh1, and withinlitter treatment was one factor with four variables: TP-male, TP-female, Veh2-male,
Veh2-female. Appropriate corrections were made for multiple comparisons (Tukey). We
used preliminary analyses to determine effects of interaction terms; if no significant
interaction was present, these terms were excluded from further analysis. For the WRA
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the effect of day on behaviors was determined using a two-way ANOVA for treatment
group and day. Note: we excluded one litter (cohort 1) from our analyses due to an
abnormally large litter size (15 pups), which resulted in the failure to thrive of 2 pups and
low body weight across the litter; this outcome prompted us to cull litters to 10 pups at P2
thereafter.
3. Results
3.1 Motor Development Tests
Surface righting. In the hits analysis, there was a significant litter effect on days
P3 and P5 (p=0.03, p=0.04, respectively); this effect appears to be driven by VPA/Veh1
treatment differences across litters. However, the number of hits was unrelated to surface
righting time for all days (p>0.29). Offspring of dams receiving VPA treatment appeared
to display longer latencies to surface right compared to offspring of Veh1 treated dams
(Fig 1-A). On P3 the average surface righting time for the VPA treatment group was 16.7
s, while the Veh1 treatment group average was 11.8 s. However, the mixed linear model
analysis showed these latency values failed to reach statistical significance on all days
measured (p>0.16). There was also no significant effect of sex or TP treatment (p>0.09)
and no interaction effects (p>0.11) across all days.
Mid-air righting. The mixed linear model analysis of mid-air righting scores by
number of hits uncovered a significant effect of hits (p=0.04, Fig 1-B) on P19 with
average number of successful righting attempts decreasing from 2.75 for both 0 and 1
hits, to 2.38 for 2 hits, and to 2.0 for 3 hits. There was also a significant effect of litter on
P13 (p=0.02) and P19 (p=0.001), and an interaction effect between hits and litter
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(p=0.04) on P19. However, analysis of scores revealed no significant effect of VPA
treatment, TP treatment, or sex (p>0.11).
Hanging Grip Strength. Hanging grip times analyzed by number of hits showed
that the effect of hits approached significance for P17 and P18 (p<0.08, Fig 1-C), but no
other days (p>0.27). On P17 the longest average hanging grip time was recorded for
Veh1-Veh2 females (0 hits, 33.4 s) and the shortest average time for VPA-TP males (3
hits, 16.7 s), with pups designated as 1 and 2 hits being intermediate (22.6 s and 19.2 s,
respectively). On P18 the average hanging grip time ranged from 27.4 s for 1 hit to 24.5 s
for 2 hits to 16.5 s for 3 hits; however, the average time for 0 hits was intermediate (22.6
s). The negative geotaxis results are not presented due to infrequency of task completion
across all cohorts. There was also a significant effect of litter on all days (p<0.03), except
P13 and P15. Pups receiving VPA treatment in utero appeared to regress in their hanging
grip strength ability, implying VPA/Veh1 treatment differences are driving the litter
effects. VPA pups displayed similar hanging grip times to Veh1 pups on early trial days
P13, P14, and P16 (p>0.18); however, VPA pups underperformed Veh1 pups with
shorter duration for hanging grip time on days P15, P17, and P19 (p=0.004, p=0.03,
p=0.04, respectively) (Fig 1-D). This effect was not influenced by TP treatment or sex
(p>0.33).
3.2 Open Field/Elevated Plus Maze
Open Field. The hits analysis showed a significant effect of litter and an
interaction effect between litter and hits on velocity in the center zone (p<0.0001,
p=0.0006, respectively). There was also a significant effect of litter on frequency of entry
into the center (p=0.0006) and edge zones (p=0.0024), but it does not appear to be driven
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by treatment group, as there was no significant effect of VPA treatment, TP treatment, or
sex on frequency, duration, or latency of zone entries in the center or edge zones (all pvalues>0.12); there was also no effect on velocity or total distance moved (p>0.28).
Overall, neither VPA nor TP treatment appeared to affect general locomotion or anxiety
(as measured by frequency and duration in center vs. edge zone) in the open field trials.
Elevated Plus Maze. The mixed linear model analysis revealed a significant effect
of litter and hits for frequency of entry into open arms (p<.0001, p=0.02, respectively)
(Fig 2-A); however, there was no interaction effect (p>0.41). VPA-TP males (3 hits) had
the highest number of entries (16.0), while Veh1-Veh2 females had the lowest frequency
of entry into open arms (11.1). There was also an effect of litter on frequency of closed
arm entries (p<0.0001). The number of hits approached, but failed to reach, significance
for open arm duration (p=0.08, Fig 2-B). Both litter and hits approached significance for
duration spent in the closed arms (p>0.08 for both). Animal velocity in the entire arena
displayed a litter effect (p<0.0001), with number of hits approaching significance
(p=0.07, Fig 2-C). The analysis found no significant effect of VPA treatment, TP
treatment, or sex on frequency or duration of zone entries in the open or closed arms of
the maze (p>0.42, Fig 2-D); there was also no effect on velocity measured for the entire
maze (p>0.53).
3.3 Wheel Running Assays
Latency of Behavior. The mixed linear model analysis revealed a significant
effect of day for latency to initiate wheel running (p<0.001) (Fig 3-A). Across all
treatment groups, latency to run was significantly less on day 2 compared to day 1
(p<0.001). The expected increase in latency to run on day 5 when compared to day 4 was
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only significantly different for Veh1-TP males (p=0.006), but was not different for all
other treatments (p>0.08). Our analysis showed no significant effect of VPA treatment,
TP treatment, or sex on latency of behavior for any behaviors measured (i.e., wheel
running, wheel interaction, grooming, burrowing, p>0.20). On day 1 there was no
difference between any treatment group, sex, litter, or number of hits for latency to run on
the wheel (p>0.20) or in latency of stereotypical behaviors, including burrowing (p>0.31)
and grooming (p>0.70). Social interaction initiation was assessed by the latency of the
mouse to contact or begin following a sex-matched novel mouse (Veh1-Veh2). Again, we
found no difference between any treatment groups or number of hits in latency to contact
(p>0.11) or follow (p>0.18) the novel mouse (Fig 3-B,C).
Duration of Behavior. Our analysis of the duration of behaviors used the
percentage of time the mouse spent performing each behavior. The results of our mixed
linear model analysis showed a significant effect of day on wheel running for all
treatment groups (p<0.0001, Fig 4-A). In a comparison of both wheel running (time spent
actively running on the wheel) and wheel interaction (time spent in the wheel, whether
running or stationary) duration times for the last day the wheel was free (day 3) vs. the
first day the wheel was jammed (day 4), and the first day the wheel was jammed vs. the
second day the wheel was jammed (day5), all p-values reached significance (p<0.0001).
We also compared wheel running and wheel interaction duration (%) for our
treatment groups across all days for days the wheel was free vs. jammed. In general, we
found no significant effect of VPA treatment, TP treatment, sex, litter, or hits on duration
of wheel running (p>0.34) or wheel interaction (p>0.63) across all days. When we looked
at these behaviors by day, we found a significant effect of hits on duration of wheel
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interaction for day 5, the second day the wheel was jammed (p=0.04). The average
percentage of time spent interacting with the wheel ranged from 14.2% for Veh1-Veh2
females (0 hits) to 22.0% for VPA-TP males (3 hits), with mice designated as receiving 1
and 2 hits being intermediate (20.1%, 17.5% respectively). However, there was no
apparent effect of VPA treatment, TP treatment, sex, or litter on wheel running (p>0.10)
or wheel interaction (p>0.22) for any other comparison by day.
Our analysis revealed that duration (%) of stereotypical behaviors, including
burrowing (p=0.035) and grooming (p<0.0001), was higher when the wheel was jammed
(day 4) when compared to a day the wheel would freely turn (day 3), see Fig 4-B for
grooming. Our duration analysis of stereotypical behaviors displayed an effect of litter
(p=0.03) and hits (p=0.02) on duration of grooming on day 1. VPA-TP males (3 hits)
spent the most time grooming (4.4%), while those designated as 1 hit groomed the least
(1.5%). We also found an effect of litter on grooming for day 5 (p=0.003) with the
interaction of litter by hits approaching significance (p=0.06). Litter had a significant
effect on burrowing behaviors for day 4 (p=0.009) and there was a litter by hits
interaction effect on day 1 burrowing behaviors (p=0.03).
As part of our social interaction test we measured duration of contact and
following behaviors initiated by the subject mouse. Although the effect of VPA treatment
appeared to cause a nominal increase in the duration of contact, this effect failed to reach
significance (p=0.19, Fig 4-C). There was also no effect of sex by TP or hits (p>.56) on
duration of contact with the novel mouse; however, there was a significant effect of litter
(p<0.001). Following behavior was also affected by litter (p<0.0001), but not hits
(p>0.43, Fig 4-D). Duration of following did not vary by VPA treatment (p=0.18, Fig 4-
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E), but there was a significant effect of sex (p=0.03) with females, regardless of TP
treatment, spending more time following the novel mouse (1.7%) than males did (0.6%).
Lastly, we evaluated the duration of social interaction (contact + following), with only
litter (p<0.0001) reaching significance.
3.4 Brain Measures
We calculated volume for the entire Cb, the cerebellar vermis, and cerebellar
hemispheres, along with the volume of the granular layer of the cerebellar vermis and
hemispheres. There was no effect of number of hits on volume measures (p>0.65).
However, there was a significant litter effect on all measures: Cb volume (p<0.0001),
vermis volume (p=0.0005), hemisphere volume (0.0004), vermis granular layer (0.0005),
and hemisphere granular layer (0.0010). We did not find any effect of VPA treatment
(p>0.81), sex by TP treatment (p>0.52), or an interaction effect between these treatments
(p>0.45) on measures of volume from any region of interest.
4. Discussion
Valproic acid is commonly used to treat epilepsy and bipolar disorder, but is
associated with congenital birth defects and impaired cognition with fetal exposure
(Meador & Loring, 2013; Roullet et al., 2013). Previous studies have assessed the effect
of prenatal VPA exposure on a battery of behaviors (Kataoka et al., 2013; Roullet et al.,
2013; Roullet et al., 2010; Schneider et al., 2008), brain morphology (Hara et al., 2012;
Ingram et al., 2000), and gene expression (Kolozsi et al., 2009; Roullet et al., 2010) in
rodents with some studies finding sex differences in postnatal behavior (Kataoka et al.,
2013; Schneider et al., 2008; Wagner et al., 2006) and sex-dependent changes in brain
morphology (Hara et al., 2012). To our knowledge, there have been no previous reports
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studying the effects of VPA in combination with exogenous pT aimed at understanding
how pT influences vulnerability to an ASD-inducing insult. We anticipated that the VPAtreated mice, as a result of altered neural development, would exhibit behaviors similar to
those seen in ASD, such as motor impairment or delay, repetitive behaviors, decreased
social interaction, heightened anxiety, and increased cognitive rigidity (inability to forgo
a routine). Secondly, due to higher levels of endogenous fT, we proposed that males
treated with VPA would have more significant behavioral abnormalities than VPAtreated females. Finally, our study was designed to assess the effect of exogenous pT, and
whether masculinizing females would increase the effect of VPA, resulting in behaviors
similar to those of VPA-treated males. We also hypothesized that males receiving both
TP and VPA (3 hits) may display increased abnormalities in behavior due to the
enhanced masculinization effect of exogenous testosterone.
Cerebellar injury is the largest single, non-heritable risk for ASD with a risk ratio
calculated at 36x the general population (Wang et al., 2014). Early disruption of
cerebellar growth is positively correlated with ASD (Courchesne et al., 2001; Hashimoto
et al., 1995) and subsequent impairment of regional volumetric growth in the
contralateral cerebrum (Limperopoulos et al., 2014). Furthermore, the Cb is one of the
brain regions most often disrupted in those with ASD, at the microscopic and gross levels
(Casanova, 2007; Palmen et al., 2004; Wang et al., 2014). The Cb is well known for its
role in balance, posture, and motor function; however, evidence now suggests the Cb also
supports higher function (Wang et al., 2014). Human functional imaging measurements
have shown that almost every part of neocortex has an associated region in the Cb as
displayed by measurements of covariation between neocortex and cerebellum, thus Cb
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abnormality potentially affects other regions implicated in ASD (Wang et al., 2014). A
meta-analysis of motor dysfunction also found a large, positive effect that indicates
significant motor coordination deficits in ASD participants occurring in approximately
80% of ASD cases (Fournier, Hass, Naik, Lodha, & Cauraugh, 2010). In addition,
regional differences in Cb structure are present in five ASD rodent models (Wang et al.,
2014), including VPA treatment (Ingram et al., 2000). Accordingly, we selected our
behavioral tasks to be relevant to Cb impairment, along with the core behavioral deficits
associated with ASD, and focused on brain morphology measures of the Cb.
We demonstrate that VPA exposure in utero negatively affects motor
development, with some measures being most affected in the triple hit group (VPA-TPmale). However, the combined effect of VPA-TP treatment in males appears to reduce
anxiety in the EPM, while also inducing a nominal increase in velocity or activity in the
maze. In the WRA, females, regardless of treatment group, displayed higher sociability as
measured by time spent following a novel mouse. The impact of prenatal VPA on motor
development suggests that this treatment has some bearing on cerebellar development;
however, this effect did not result in significant volumetric differences in the Cb. The
results of the hits analyses suggest that pT could act through some mechanism to increase
vulnerability of males to our autism-inducing insult, but further study is needed to better
understand this mechanism.
Dufour-Rainfray et al. (2010) assessed motor development in rats exposed to 600
mg/kg VPA on E9 (Dufour-Rainfray et al., 2010). They found no significant difference in
behavior between the VPA and control group across all tests, including righting reflex,
gait reflex, negative geotaxis, response to tactile stimulation, and rope suspension
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(Dufour-Rainfray et al., 2010). On the other hand, Wagner et al. (2006) evaluated motor
development in BALB/c mice following a 600 mg/kg dose of VPA on E13 (Wagner et
al., 2006). Their findings revealed VPA treatment impaired surface righting and mid-air
righting abilities independent of sex and that hanging grip time was reduced in VPA
exposed mice, with VPA males outperforming VPA females; however, there was no
difference between treatment groups in negative geotaxis or balance beam tasks (Wagner
et al., 2006). While our results indicated that surface righting and mid-air righting were
unaffected by VPA treatment, sex, and TP treatment, we did find a significant effect of
number of hits on the last day of the mid-air righting test with the average number of
successful attempts decreasing as number of hits increased. This could indicate that the
combined effect of VPA-TP treatment in males caused a regression in mid-air righting
ability on P19. In our hanging grip test, both VPA and Veh1 animals displayed similar
hang times on the first day of the test. VPA treatment, independent of sex and TP
treatment, appeared to reduce hanging grip time for subsequent days of the test with this
difference reaching significance on days P15, P17, and P19, consistent with the findings
by Wagner et al. (2006) that VPA treatment results in a delay to maturation in this skill
(Wagner et al., 2006). The results of the hanging grip task also suggest that increasing
number of hits resulted in worse performance on later days of this task; these values
approached significance on P18 and P19.
Mehta et al. (2011) treated pregnant C57BL/6Hsd (B6) mice with 600 mg/kg
VPA on E13 and found that mice exposed to VPA exhibited a reduction in the frequency
of center zone entries during open field testing from P56-P64 when compared to saline
exposed mice; however, duration in the center zone and overall locomotor activity were
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not difference between the two groups (Mehta et al., 2011). Another study using the same
mouse strain and VPA treatment regimen found no differences in open field behavior or
locomotor activity between treatment groups (Gandal et al., 2010). Our results suggest
that VPA treatment, sex, TP treatment, and number of hits did not affect frequency of
zone entry or zone duration in the open field trial, indicating no difference between
groups in general locomotion or anxiety during this trial.
Schneider et al. (2008) evaluated sexual dimorphic effects of VPA on a battery of
tests in Wistar rats treated in utero with 600 mg/kg VPA on E12.5 (Schneider et al.,
2008). For EPM they found similar levels of locomotor activity and frequency of entries
into the closed arms when comparing the VPA treatment group to controls, while females
were more active than males (Schneider et al., 2008). The male VPA treated rats spent
less time and had fewer entries into the open arms of the maze, indicating higher anxiety;
VPA females’ behavior was similar to that of control males, while control females
displayed the lowest measures of anxiety on this task (Schneider et al., 2008). While we
found no significant effect of VPA treatment, TP treatment, or sex on frequency or
duration of arm entries or an effect on overall velocity, we did find some effects of the
number of hits. Opposing the expected pattern of behavior, the Veh1-Veh2 females (0
hits) had the fewest entries into the open arms, and the VPA-TP males (3 hits) had the
most entries into the open arms, indicating VPA-TP males (3 hits) displayed the lowest
levels of anxiety in this task. The VPA-TP males also had the longest duration in the
open arms, also indicating low anxiety; this measure approached significance. Animal
velocity also nearly reached significance, with the VPA-TP males displaying the highest
average velocity. Hyperlocomotor activity could be one factor leading to an increased
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frequency of entries into the open arms for the VPA-TP males; the study by DufourRainfray (2010) also found hyperlocomotor activity in male rats treated with VPA
(Dufour-Rainfray et al., 2010). Increased activity, however, fails to justify the VPA-TP
males’ longer duration in the open arms of the maze.
Wheel running behaviors have been explored in rodents in many contexts, e.g.,
locomotor activity, energy balance, obesity, and circadian rhythm (Novak, 2012), and are
consistently appraised as rewarding activities (Werme et al., 2002). Karvat and Kimchi
(2012) used the wheel running proclivity in mice to develop a behavioral test applicable
to autism-like behaviors (Karvat & Kimchi, 2012). They designed this assay to assess
features of autism including rigidity to change habits, repetitive stereotypical behaviors
and impaired social interactions; their results showed that BTBR mice, a strain known to
exhibit a robust autism phenotype, displayed higher levels of burrowing and grooming,
heightened cognitive rigidity, and reduced social interaction (Karvat & Kimchi, 2012).
Our prior work exploring sex differences in pre-pubertal mice found that 3 commonly
used strains displayed no impairments in behavior as measured by this assay, nor were
any baseline sex differences in behavior evident (Gordon & Corbitt, 2015).
As shown in our previous study using the WRA to assess sex differences in prepubertal mice, latency to run on the wheel should decrease following the initial
introduction of the mice to the novel wheel (Gordon & Corbitt, 2015). In this study we
found that latency to wheel run was shorter on the 2nd day of the assay compared to the
1st, indicating all treatment groups displayed normal routine gaining. The WRA is
designed to measure cognitive rigidity, which is assessed by indicators of ability to break
a routine. We measured cognitive rigidity by comparing latency to run on the wheel on
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day 4 (1st day jammed) with day 5 (2nd day jammed); while latency appeared to increase
for the Veh1 groups, this increase was significant only in the Veh1-TP males. This
indicates that all treatment groups in our study, except for Veh1-TP males, demonstrated
impaired cognitive rigidity or memory, i.e., the mice failed to break routine of wheel
access or did not remember the wheel was jammed. We expected indications of cognitive
rigidity impairment in VPA treatment groups, but not in our Veh1-treated mice. The
behavior of control mice in this study was different than in our previous work where we
saw increased latency of hundreds of seconds (Gordon & Corbitt, 2015). One possible
explanation could be increased stress levels, both prenatal and postnatal. All dams,
regardless of treatment group received injections on E12.5. While this procedure was
performed quickly, it undoubtedly activated the dam’s stress response. In addition, pups
were separated from dams for brief periods early in development (P2-P8 and P13-P19) to
perform tail clip, tattooing, and motor development testing. This separation can lead to
increased stress in both the dam and the pups. Many studies have shown cognitive and
behavioral deficits in rodents exposed to pre- and post-natal stress (Emack et al., 2008;
Franklin et al., 2010; Markham et al., 2010; Mueller & Bale, 2007).
All mice in this study followed the expected pattern of wheel running duration,
with heightened wheel running duration on days the wheel was free compared to those
when the wheel was jammed. The mice in our study, regardless of treatment group, also
maintained their ability to forfeit the running habit when the wheel was jammed, as
displayed by reduced wheel interaction on days 4 and 5 of the assay. While latency
measures indicated some increase in cognitive rigidity, reduced wheel interaction on days
4-5 shows that the mice were capable of changing habits. However, on day 5 of the assay
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there was an effect of hits on duration (%) of wheel interaction (but not wheel running),
with Veh1-Veh2 females (0 hits) spending the least amount of time and VPA-TP males
(3 hits) the most time interacting with the wheel (data not shown), demonstrating that
although VPA-TP males spent less time interacting with the wheel on day 5 compared to
day 4, they spent relatively more time interacting with the wheel on day 5 compared to
the other treatment groups. Therefore, the combined effect of VPA, TP and male sex
appeared to increase cognitive rigidity on this day.
Previous work by Gandal et al. (2010) using C57BL/6Hsd (B6) mice treated
prenatally with 600 mg/kg VPA on E13 demonstrated that VPA-treated mice had
increased repetitive self-grooming behaviors. The aforementioned study by Mehta et al.
(2011) also found that rodents exposed to VPA displayed higher levels of self-grooming
compared to controls. Our study revealed an effect of hits on self-grooming duration on
day 1 with VPA-TP males (3 hits) spending the most time in this activity and the 1-hit
group grooming the least. This increase in repetitive behaviors provides evidence that
exogenous TP treatment increases vulnerability in males to the effects of VPA. However,
this support is limited in scope, as the increase in self-grooming in VPA-TP males is
limited to day 1 of the WRA. Our analysis of VPA treatment, TP treatment, and sex
failed to provide more information regarding which treatment resulted in increased
grooming, as no factor reached statistical significance for latency to initiate stereotypical
behavior, i.e., self-grooming or burrowing. We also saw that overall, self-grooming and
burrowing behaviors were diminished when the wheel was free when compared to days
the wheel was jammed, indicating all treatment groups preferred wheel running to
performing these stereotypical behaviors.
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Given that ASD is characterized by impairments in social interaction, numerous
studies have measured social behaviors in VPA rodent models. The studies by Gandal et
al. (2010) and Roulett (2010) found mice treated with VPA displayed a decreased social
preference in comparison to the control mice (Gandal et al., 2010; Roullet et al., 2010).
Kim et al. (2011) demonstrated that Sprague-Dawley rats exposed at E12 to 400 mg/kg
VPA had lower levels of sociability and social preference (K. C. Kim et al., 2011). The
work by Dufour-Rainfray (2010) indicated VPA rats initiated fewer social approaches
than controls, but had no other signs of social deficits (Dufour-Rainfray et al., 2010). In
Kataoka’s (2013) study, researchers found a sexually dimorphic response to VPA
treatment, with only male mice exhibiting reduced social behavior (shorter duration of
sniffing); however, there was no effect on allogrooming or aggression in either sex
(Kataoka et al., 2013). Conversely, Narita et al. (2010) found no differences in social
behaviors (sniffing, dominant status, allogrooming, pinning, chasing, or aggressive
behaviors) between rats exposed to VPA (800mg/kg) on E9 and control rats (Narita et al.,
2010).
Our previous work using this WRA to assess wheel running and social behaviors
in 3 strains of mice revealed no sex difference in social behaviors (Gordon & Corbitt,
2015). In the current study we found no difference in latency to initiate social behaviors,
e.g., contact or following. However, females in this study spent more time following the
novel mouse than males; this effect was consistent across all treatment groups. The sex
difference in following behaviors could indicate that males in our study were more
influenced by the pre- and post-natal stress that was inherent to the design of our study.
Other studies have also reported a sexually dimorphic response to maternal stress (Emack
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et al., 2008; Franklin et al., 2010; Markham et al., 2010; Mueller & Bale, 2007). Previous
studies suggest that VPA treatment has a negative effect on social behavior (DufourRainfray et al., 2010; Gandal et al., 2010; K. C. Kim et al., 2011; Roullet et al., 2010),
especially in males (Kataoka et al., 2013). Therefore, the VPA treated mice in our study,
males in particular, should be expected to spend less time in social contact. Our results
revealed that Veh1-Veh2 females (0 hits) spent the shortest duration (%) and the VPA-TP
males (3 hits) had the longest duration (%) of contact with the novel mouse. Conversely,
VPA-TP males spent the least amount of time participating in following behaviors, while
the 1-hit group spent the most time pursuing the novel mouse. The effect of hits on
contact and following behaviors, however, failed to reach significance. Since our analysis
used percentage of time spent performing behaviors, we analyzed the combined duration
of all social behaviors (contact + following), but found social behavior was only
influenced by litter. The overall trend of social behaviors was opposite our expectations
with the Veh1-Veh2 females spending the least amount of time interacting socially, while
the VPA-TP males spent the most time. One possible explanation is that we used a novel
method to assess social interaction in the VPA rodent model by choosing the WRA.
Many of the prior studies have used social preference tasks.
Our study produced varied results across the battery of behavioral tasks.
Assessment of motor development tests provided support for our hypotheses. We found
both delayed development and regression of skill in motor development tasks in VPAtreated pups, which supports previous work in this field. We also found some indication
that the combined effect of VPA, TP, and maleness (triple hit) resulted in worse motor
development outcomes compared to other treatment combinations with fewer hits.
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Demonstrating a lack of support for our hypotheses, we found no anxiety impairments in
the open field task, and the EPM results revealed that VPA-TP males showed decreased,
rather than the expected increased, anxiety. The WRA assay results were mixed. We
found no major effects on cognitive rigidity in our WRA assay, aside from VPA-TP
males spending more time with the wheel compared to other groups on day 5. Increased
stereotypical behaviors were limited to day 1 of the WRA when VPA-TP males displayed
increased self-grooming behaviors. Surprisingly, the social interaction component of the
WRA trended towards VPA-TP males spending the most time in social interaction
(18.8%), which represents 27.6 s more social contact than the least social group (Veh1Veh2 females). Finally, we found no reduction of Cb volume, either regional or total
cerebellar, as predicted based on previous findings. On the other hand, we found
impairments in motor development, which are thought to be associated with cerebellar
maturation. Therefore, we cannot rule out an effect of VPA on Cb function even though
we did not find significant differences in our gross volume measures.
One weakness of our study is the use of a drug as the autism-inducing insult. With
the variability seen across human and animal studies resulting from different VPA doses,
the timing of administration, and delivery method, it is important to consider the
pharmacokinetics of VPA and how that relates to our murine model. In clinical studies,
VPA administration during pregnancy is associated with adverse outcomes, such as
congenital malformations, cognitive disability, and risk of ASD with risk of such
negative outcomes increasing with higher daily doses of VPA (Roullet et al., 2013). In
rodent studies, all VPA doses tested (200–800 mg/kg) alter neurodevelopment; yet, a
precise dose threshold for this ASD model has not been clearly identified (Roullet et al.,
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2013). While the half-life in humans is 9-18 hours, the rat displays dose-dependent
nonlinear elimination kinetics and a lower half-life of 2-5 hours and the elimination halflife in the mouse is even faster, at 0.8 hours (Loscher, 1999). The brain/plasma ratios of
VPA are similar in all species investigated, but the other pharmacokinetic differences
lead to the higher VPA doses needed in rodents to obtain equivalent plasma levels as in
humans (Loscher, 1999). The rodent VPA model has been studied for many years;
however, the timing, dose, and delivery method of VPA is inconsistent across studies,
resulting in variability of autism-like behavior and brain development outcomes in these
models (Gandal et al., 2010; Hara et al., 2012; Kataoka et al., 2013; Mehta et al., 2011;
Roullet et al., 2010; Wagner et al., 2006). Due to the fact that the endogenous
testosterone surge in rodents occurs immediately after birth, we chose to give our TP
treatment at this time. However, this resulted in the VPA and TP treatments being
separated by 8-10 days. It is unknown how this lag between treatments affects the
practicality of this design. Another weakness of this study is the possible confounding
stress effect. While we could ensure that all treatment groups experienced the same
procedures which were likely to induce stress (prenatal maternal stress from VPA or
Veh1 injection and postnatal stress from handling and maternal separation), we cannot
confirm that all reactions to stress or separation were the same across litters. Differences
in reactions to stress may help explain litter effects seen in our hits analyses, which were
not always due to treatment (VPA/Veh1) differences among litters.
While the results of this study indicated effects of VPA treatment and sex on
multiple behavioral tasks, we did not find the expected associations between the
combinations of VPA and TP treatments with sex. By also analyzing data by hits, we
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found indications that the combined effects of VPA and TP treatment in males increases
the severity of behavioral impairment in some tasks. While we show that the triple hit of
VPA-TP treatment in males appears to negatively impact the development of some skills
(motor development, cognitive rigidity, and stereotypical behaviors) more severely in this
group compared to other treatments, some outcomes were unaffected (social interaction)
or even enhanced in this group (anxiety). The mechanisms underlying the previously
reported sexual dimorphic effects of VPA remain unclear. Further studies in rodents are
needed to more clearly identify the appropriate timing, dose, and delivery method of
VPA and TP to achieve a more reliable model of ASD and to better understand the
mechanism by which increasing pT intensifies vulnerability to autism-inducing insults,
such as VPA, in males.
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Table 1. Treatment (Tx) Groups
Dam Tx (E12.5)

Pup Tx (P2)

Sex

Final Tx Groups

# of Hits

n

VPA

TP

M

VPA + TP

3

10

TP

F

VPA + TP

2

11

Veh2

M

VPA + Veh2

2

11

Veh2

F

VPA + Veh2

1

11

TP

M

Veh1 + TP

2

14

TP

F

Veh1 + TP

1

14

Veh2

M

Veh1 + Veh2

1

12

Veh2

F

Veh1 + Veh2

0

13

Veh1
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Figure 1: Duration or score of motor development behaviors by day (mean ± SEM). A)
surface righting time by VPA treatment, B) mid-air righting score by number of hits, C)
hanging grip time by number of hits, D) hanging grip time VPA treatment. ab Differing
superscripts indicate statistically significant difference (p < 0.05).
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Figure 2: Frequency, duration, and velocity measures from EPM (mean ± SEM). A)
frequency of zone entry by number of hits, B) duration in open vs. closed arms by
number hits, C) velocity in arena by number of hits, D) duration in open vs. closed arms
by treatment group. ab Differing superscripts indicate statistically significant difference (p
< 0.05).
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Figure 3: Latency of behaviors from WRA (mean ± SEM). A) wheel running by
treatment group, B) contact with the novel mouse by treatment group, C) following novel
mouse by treatment group. Note: * = first day the wheel was jammed. When the wheel is
jammed, “wheel running” is defined as any activity that would make the wheel move if it
were free.

**

Indicates statistically significant difference (p < 0.05).
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Figure 4: Duration of behaviors from WRA (mean % ± SEM). A) wheel running by
treatment group, B) grooming by treatment group, C) contact with the novel mouse by
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treatment group, D) following novel mouse by number of hits, E) following novel mouse
by treatment group. Note: * = first day the wheel was jammed. When the wheel is
jammed, “wheel running” is defined as any activity that would make the wheel move if it
were free.

ab

Differing superscripts and

**

indicates statistically significant difference (p <

0.05).
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CHAPTER 4
SUMMARY AND FUTURE DIRECTIONS
Summary
This dissertation represents a compilation of work aimed at expanding our
understanding of sex differences in autism incidence, using a mouse model to evaluate
whether elevated levels of perinatal testosterone (pT) affect the vulnerability of each sex
to an autism-inducing insult. In Chapter 1, I discuss relevant literature on the sex bias in
autism spectrum disorders, drawing on both clinical and animal models. Chapter 2
establishes baseline wheel running and social interaction behavior in pre-pubertal mice
using an assay designed to measure autism-like behavioral deficits. These results suggest
that there are no sex differences in wheel running behaviors or social interaction across 3
strains of mice. Findings from Chapter 3 support the premise that valproic acid (VPA)
exposure impairs motor development abilities in mice and provides evidence that the
combined effects of an autism-inducing insult (VPA), along with elevated pT
(testosterone propionate, TP) and maleness (triple hit), results in worse performance on
some motor development measures and increases cognitive rigidity and self-grooming
behaviors compared to control females. This triple hit also led to some unexpected
outcomes, such as reduced anxiety compared to other treatment groups. Finally, we found
no associations between VPA treatment, pT treatment, or sex on cerebellar volume
measures. Overall, these results offer limited support for the hypothesis that elevated
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levels of pT increases vulnerability to an autism-inducing insult. However, more research
is needed in mice to
better validate this model and to elucidate the mechanism by which pT can increase
susceptibility to autism-inducing insults, such as VPA.
Future Directions
As discussed in Chapter 3, prenatal treatment with VPA resulted in abnormal
motor development, behaviors whose maturation are known to be associated with
cerebellar development (Wagner et al., 2006). However, the effect of VPA on cerebellar
development did not result in significant gross volumetric differences. In addition to
associations with reduced Purkinje cell number and cerebellar volume (Ingram et al.,
2000), VPA treatment in rodent models is linked to decreased neuroligin 3 mRNA
expression (Kolozsi et al., 2009), increased corticosterone and decreased immunological
activity (Schneider et al., 2008), and lower cortical expression of brain-derived
neurotrophic factor (BDNF) mRNA (Roullet et al., 2010), all of which are relevant to
autism spectrum disorders (ASD).
During the experiments outlined in Chapter 3, I reserved a small sample of 16
mice from cohort 3 for post-processing to allow for a gene expression pilot study. My lab
is currently pursuing funding to extract total RNA from a hemi-cerebellum from each
mouse for RNA-Seq assessment of differential gene expression among our treatment
groups. As I have found no prior studies of gene expression in VPA rodent models which
focus on the cerebellum (Cb), RNA-Seq provides information on highly differentially
expressed genes for targeted immunohistochemistry (IHC) follow up using our second
series of sagittal brain sections from the 80 mice that underwent intracardial perfusion.
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Alternately, if the RNA-Seq pilot is not pursued, real-time PCR could be performed on
cerebellar vermis and hemisphere samples. I propose five genes of interest (Bdnf, Dpp6,
Galnt13, Astn2, and Ptchd1) because they are known to be associated with ASD and are
expressed in the cerebellar cortex of both humans and mice (Menashe et al., 2013), and in
the case of Bdnf, because VPA decreases its expression in the mouse somatosensory
cortex (Roullet et al., 2010) and steroid-induced BNDF is important for Purkinje cell
development and connectivity in postnatal rodents (Tsutsui, 2008).
Given that the results from the hits analyses suggest that pT could be acting to
increase vulnerability of males to our autism-inducing insult, further studies designed to
understand the mechanisms of testosterone (T) action that increase susceptibility to VPA
treatment may be warranted. Recent studies investigating postnatal Cb steroidogenesis
and development, but without an autism-inducing component, point to possible next steps
to generate hypotheses to investigate mechanisms. The Cb develops later than many other
brain regions, making it particularly vulnerable to postnatal perturbations (Dean &
McCarthy, 2008). The rodent Cb has LH-dependent de novo neurosteroidogenesis and all
pathway components to get from cholesterol to 17β-estradiol (E2) (El Hajj Chehadeh et
al., 2014); the Cb expresses both estrogen receptor subtypes throughout postnatal
development, but androgen receptors appear later, at some point between P7 and P20
(Qin et al., 2007), suggesting that early T effects on Cb are mediated by its metabolite E2.
Postnatal male rats produce a spike in mRNA for steroidogenic pathway components
(StAR protein, p450scc, and aromatase) at P10, with females producing significantly less
than males and their aromatase mRNA spike occurring earlier, at P5 (Lavaque, Mayen,
Azcoitia, Tena-Sempere, & Garcia-Segura, 2006). Injecting female rats at P1 with
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12.5mg/rat TP to mimic the postnatal gonadal T surge in males did not alter their Cb
steroid pathway mRNA levels at P10 compared to oil-injected females (Lavaque et al.,
2006), but Cb steroid levels were not measured. This result indicates that effects of pT
are probably not via its effects on de novo steroidogenesis in the Cb, or if they are, then a
previous insult (such as VPA) is also necessary. Allopregnanolone, progesterone, and E2
from Purkinje cells organize Cb maturation, in part by stimulating BDNF expression,
which is necessary for postnatal Cb maturation and connectivity; aromatase knockout
(ArKO) mice express decreased Bdnf in Cb and decreased Purkinje cell maturation
compared to wild types or ArKO mice given supplemental estrogen neonatally (Tsutsui,
2008), pointing to a beneficial role of locally-produced E2. Therefore, Cb
neurosteroidogenesis is a logical next step to pursue. A recent study in rats demonstrates
that overstimulation with E2 may be detrimental; prostaglandin-stimulated E2 production
in the Cb at P10-12 stunted Purkinje cell dendritic arbors and altered their
electrophysiological properties in both males and females (Dean, Knutson, Krebs-Kraft,
& McCarthy, 2012). Perhaps extra-cerebellar T (gonadal or exogenous), acting as E2 on a
VPA-disordered brain, overwhelms normal processes of Cb development, leading to
increased autism-like effects in triple hit males compared to control females.
The proposed studies will provide information on gene expression and help
further elucidate mechanisms of testosterone action that increase susceptibility to VPA
treatment. The results of the current experiments, while not fully supporting our
hypotheses, provide some evidence that elevated levels of pT increase vulnerability to an
autism-inducing insult in our mouse model. This warrants further study using this VPATP model with the caveat that more data is needed to identify the appropriate timing,
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dose, and delivery method of VPA and TP to attain a reliable model of ASD. The sex
bias in ASD remains one of the hallmark features of this condition, and undoubtedly a
better understanding of this difference in incidence can provide much needed information
about the underlying causes.
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